rsID,gene,condition,variant_type,consequence,chromosome,position,protein_change,clinical_sig,ref_allele,alt_allele,variant_id,position_clean,gene_primary,chrom_clean,gnomAD_AF,gnomAD_AF_AFR,gnomAD_AF_AMR,gnomAD_AF_EAS,gnomAD_AF_EUR,gnomAD_AF_SAS,expected_carriers,actual_carriers
rs1644506661,PLEKHG5,Juvenile amyotrophic lateral sclerosis,single nucleotide variant,missense variant,1,6469588,"P630H, P699H, P707H, P667H",Likely pathogenic,C,A,rs1644506661,6469588.0,PLEKHG5,1,0.001984483508065276,0.0021651921332052943,0.0024504107158912075,0.001775973985541834,0.0016289981882849727,0.001901842517403072,59,48
rs1435710212,PLEKHG5,Juvenile amyotrophic lateral sclerosis,single nucleotide variant,nonsense,1,6470860,"Q550*, Q473*, Q542*, Q510*",Pathogenic,C,T,rs1435710212,6470860.0,PLEKHG5,1,0.0005119193384933538,0.0004854013729382447,0.0004188274060574185,0.00032546682416735817,0.0007257578714313261,0.0006041432178724216,15,13
rs1553122918,PARK7,Amyotrophic lateral sclerosis-parkinsonism-dementia complex,single nucleotide variant,nonsense,1,7965366,Q45*,Pathogenic,C,T,rs1553122918,7965366.0,PARK7,1,0.0009053576206486484,0.0007947708324014249,0.0009256870646853704,0.0005130241965622144,0.001155250116121409,0.001138055893472824,27,21
rs80356723,TARDBP,"FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED|Amyotrophic lateral sclerosis type 10",single nucleotide variant,missense variant,1,11022292,,Pathogenic,G,A,rs80356723,11022292.0,TARDBP,1,0.001655037690337666,0.0019398194285724583,0.0018294658976559185,0.0017792822826990708,0.001344656489420028,0.001381964353340854,49,53
rs1304706298,TARDBP,"Amyotrophic lateral sclerosis type 10|FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED",single nucleotide variant,missense variant,1,11022371,A321D,Likely pathogenic,C,A,rs1304706298,11022371.0,TARDBP,1,0.004596186934656299,0.00448098155761079,0.0048110737891987115,0.005616570642229933,0.0041065248265372885,0.0039657838577047706,137,124
rs80356732,TARDBP,"FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED|Amyotrophic lateral sclerosis type 10",single nucleotide variant,missense variant,1,11022444,N345K,Pathogenic,C,A,rs80356732,11022444.0,TARDBP,1,0.0024117950699734498,0.003057510892376685,0.002151107690150341,0.0021428952183698015,0.0026245379304954517,0.0020829236184749696,72,63
rs1643659556,TARDBP,Amyotrophic lateral sclerosis type 10,single nucleotide variant,missense variant,1,11022469,Q354E,Likely pathogenic,C,G,rs1643659556,11022469.0,TARDBP,1,0.003827112938173285,0.003921329849579165,0.003640600623562032,0.00427844727026906,0.00365082502232207,0.0036443619251340974,114,141
rs766196255,TARDBP,"FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED|Amyotrophic lateral sclerosis type 10",single nucleotide variant,missense variant,1,11022532,S375G,Pathogenic,A,G,rs766196255,11022532.0,TARDBP,1,0.000323580712219335,0.0003617220056320893,0.00029390853556641924,0.0002556616576031018,0.0003912749122955018,0.00031533644999956294,9,9
rs1557660662,TARDBP,"Amyotrophic lateral sclerosis type 10|FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED",single nucleotide variant,missense variant,1,11022541,N378D,Likely pathogenic,A,G,rs1557660662,11022541.0,TARDBP,1,0.0011108870946540143,0.0015930719431167346,0.001095152664886883,0.0011008582472617978,0.0010059647576800773,0.0007593878603245789,33,48
rs1553159739,TARDBP,Amyotrophic lateral sclerosis type 10,single nucleotide variant,missense variant,1,11022542,N378S,Likely pathogenic,A,G,rs1553159739,11022542.0,TARDBP,1,0.004016106916158281,0.006427968668744809,0.003061765586164164,0.0021112610094697515,0.004629072238915141,0.0038504670774975416,119,117
rs766653950,DCTN1,"Amyotrophic lateral sclerosis type 1|Perry syndrome|Neuronopathy, distal hereditary motor, type 7B",single nucleotide variant,missense variant|non-coding transcript variant,2,74361513,"R1258C, R1268C, R1141C, R1250C, R1252C, R1275C, R1136C, R1233C",Likely pathogenic,C,T,rs766653950,74361513.0,DCTN1,2,0.0010456172447981774,0.0014431159086020484,0.0006817971943319998,0.0005833621137523189,0.0012185076483022593,0.0013013033590022604,31,31
2:74362643 - 74362727,DCTN1,"Amyotrophic lateral sclerosis type 1|Neuronopathy, distal hereditary motor, type 7B",Deletion,splice acceptor variant|splice donor variant,2,74362643 - 74362727,,Likely pathogenic,N,-,2:74362643 - 74362727,74362643.0,DCTN1,2,0.00013325282246991055,0.0001437919629488289,0.00018399192199855172,0.00011781049014494377,0.00010488813387125832,0.00011578160338597013,3,3
rs1328116832,DCTN1,Amyotrophic lateral sclerosis,single nucleotide variant,missense variant|non-coding transcript variant,2,74368122,"I488F, I585F, I599F, I602F, I605F, I615F, I622F",Likely pathogenic,A,T,rs1328116832,74368122.0,DCTN1,2,0.0035525171521705867,0.004018639402003875,0.0027255113262224474,0.004507097686841635,0.003793368824791826,0.0027179685209931482,106,84
rs2529170080,DCTN1,"Amyotrophic lateral sclerosis type 1|Perry syndrome|Neuronopathy, distal hereditary motor, type 7B",Duplication,frameshift variant|non-coding transcript variant,2,74371555 - 74371556,"L190fs, L76fs, L193fs, L203fs, L210fs, L173fs, L187fs",Pathogenic,N,NN,rs2529170080,74371555.0,DCTN1,2,0.00021577332937529974,0.000285303920824379,0.00026490877165429006,0.0001771641968552999,0.00017374506863196477,0.00017774468891056493,6,4
rs1553466434,DCTN1,"Neuronopathy, distal hereditary motor, type 7B",single nucleotide variant,splice donor variant,2,74377998,,Pathogenic,T,C,rs1553466434,74377998.0,DCTN1,2,0.0007201590879314126,0.0006306226291599405,0.000972372206064125,0.0008508686080007265,0.0007142386810201142,0.00043269331541215706,21,20
rs121909342,DCTN1,"Neuronopathy, distal hereditary motor, type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome",single nucleotide variant,missense variant|non-coding transcript variant,2,74378104,"G42R, G59R",Pathogenic,G,C,rs121909342,74378104.0,DCTN1,2,0.001239729229700991,0.0010733308175817579,0.001844924851473721,0.0009549633781084742,0.0013884355539920728,0.0009369915473489293,37,33
rs121909342,DCTN1,"Perry syndrome|Neuronopathy, distal hereditary motor, type 7B|Amyotrophic lateral sclerosis type 1",single nucleotide variant,missense variant|non-coding transcript variant,2,74378104,"G59S, G42S",Pathogenic,G,A,rs121909342,74378104.0,DCTN1,2,0.0018671440924023287,0.0018840431678051463,0.0017335317583451087,0.001338571059327683,0.0020148106068588103,0.0023647638696748944,55,51
rs1014953504,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice donor variant,2,201704453,,Likely pathogenic,G,A,rs1014953504,201704453.0,ALS2,2,0.0003171515875910186,0.0004348284190446166,0.00033687221948834156,0.00027203125387851554,0.00023672449703277405,0.00030530154851084537,9,12
rs1167814155,ALS2,Infantile-onset ascending hereditary spastic paralysis,Deletion,splice donor variant,2,201704453,,Pathogenic,N,-,rs1167814155,201704453.0,ALS2,2,0.0007087151482273589,0.0009293993441222154,0.0005961668092534461,0.0005794612650967769,0.0008139981448525136,0.0006245501778118432,21,18
rs1689580631,ALS2,"Amyotrophic lateral sclerosis type 2, juvenile",single nucleotide variant,missense variant,2,201704484,P1603L,Likely pathogenic,C,T,rs1689580631,201704484.0,ALS2,2,0.002120217055227801,0.0022975313441364912,0.0016099065253383758,0.0020384579298541607,0.0024275606911824546,0.0022276287856275202,63,81
rs1689584119,ALS2,"Amyotrophic lateral sclerosis type 2, juvenile",Microsatellite,frameshift variant,2,201704537 - 201704538,S1585fs,Likely pathogenic,N,NN,rs1689584119,201704537.0,ALS2,2,0.0008676934477862379,0.0007499421593018335,0.0006366043970866975,0.0012563670955325005,0.0007535695766402832,0.0009419840103698746,26,18
rs1337097412,ALS2,Infantile-onset ascending hereditary spastic paralysis,Duplication,frameshift variant,2,201706878 - 201706879,I1517fs,Pathogenic,N,NN,rs1337097412,201706878.0,ALS2,2,0.00046218053029636246,0.0007326167997750544,0.0003239255172848366,0.0004392308693030524,0.00039160934719170796,0.00042352011792716075,13,12
rs1391892163,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,nonsense,2,201706898,R1510*,Pathogenic,C,T,rs1391892163,201706898.0,ALS2,2,0.00027780967587935987,0.0003708390474312278,0.0002807286828985724,0.00024405136533706487,0.00029491301851849837,0.00019851626521143586,8,9
rs1263013448,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice donor variant,2,201707867,,Likely pathogenic,T,A,rs1263013448,201707867.0,ALS2,2,0.000592833817024756,0.0008666577287692707,0.0004022399052006964,0.0003645139717209373,0.00041893739305530866,0.0009118200863775667,17,19
rs2105969251,ALS2,Infantile-onset ascending hereditary spastic paralysis,Deletion,frameshift variant,2,201707904,K1457fs,Pathogenic,N,-,rs2105969251,201707904.0,ALS2,2,0.0005961490915260633,0.0008958098927411874,0.0005116747802904306,0.00038491298348885237,0.0006832750364518234,0.0005050727646580232,17,12
rs2105972075,ALS2,"Amyotrophic lateral sclerosis type 2, juvenile",single nucleotide variant,nonsense,2,201709938,L1408*,Pathogenic,T,A,rs2105972075,201709938.0,ALS2,2,0.0001283014951462646,0.00019210999022877998,0.00010395836581876825,0.00012871929310007114,8.288324495204404e-05,0.00013383658163165966,3,5
rs1213175712,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice acceptor variant,2,201710040,,Likely pathogenic,A,G,rs1213175712,201710040.0,ALS2,2,0.00020986046064744426,0.0001557600704355121,0.00026413875110414456,0.00010836492310698432,0.00026648672536307025,0.00025455183322751026,6,10
rs770096661,ALS2,"Amyotrophic lateral sclerosis type 2, juvenile|Juvenile primary lateral sclerosis|Infantile-onset ascending hereditary spastic paralysis",Deletion,frameshift variant,2,201711049,Q1355fs,Likely pathogenic,N,-,rs770096661,201711049.0,ALS2,2,0.00019491684198203566,0.000301681908519256,0.0002011079544578471,9.652253787338316e-05,0.00019395201849812448,0.00018131979056156775,5,5
rs1690335308,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice donor variant,2,201715671,,Likely pathogenic,G,A,rs1690335308,201715671.0,ALS2,2,0.0009300684624930233,0.000904567640419095,0.0010893758102019544,0.0005775511062212678,0.0012257521503485985,0.0008530956052742,27,27
rs2469724450,ALS2,"Amyotrophic lateral sclerosis type 2, juvenile",Deletion,frameshift variant,2,201715783,D1298fs,Likely pathogenic,N,-,rs2469724450,201715783.0,ALS2,2,0.0010126921405320816,0.0013602304083085149,0.0008030205673609205,0.0007590522163662674,0.001476870509581805,0.0006642870010428992,30,23
rs1690523978,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,nonsense,2,201718084,K1277*,Pathogenic,A,T,rs1690523978,201718084.0,ALS2,2,0.0008336348705102606,0.0008841752341681797,0.0012484365999098908,0.0008436760585810924,0.0004875730028757428,0.0007043134570163976,24,30
rs2469734144,ALS2,Infantile-onset ascending hereditary spastic paralysis,Duplication,frameshift variant,2,201718113 - 201718114,S1267fs,Pathogenic,N,NN,rs2469734144,201718113.0,ALS2,2,0.000759544477764054,0.001005555371659995,0.0008831506391811815,0.00045069879470968345,0.0008571872845428199,0.0006011302987265904,22,26
rs1690532210,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice acceptor variant,2,201718212,,Pathogenic,A,C,rs1690532210,201718212.0,ALS2,2,0.0007955798193451044,0.0010149313153003526,0.0008831050599101413,0.0004535605866394301,0.000574241751123884,0.0010520603837517134,23,22
2:201723059,ALS2,"Amyotrophic lateral sclerosis type 2, juvenile",single nucleotide variant,nonsense,2,201723059,W1229*,Likely pathogenic,G,A,2:201723059,201723059.0,ALS2,2,0.0002901120069002423,0.0003507279408698154,0.0003437909605389261,0.0001825312347936574,0.00032326287727950506,0.00025024702101930754,8,8
rs2105998730,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice donor variant,2,201723329,,Likely pathogenic,G,A,rs2105998730,201723329.0,ALS2,2,0.0005243974861836554,0.0004977252309238937,0.00036766807830799006,0.0005690187266106089,0.0006684077498588778,0.0005191676452169068,15,17
rs386134187,ALS2,Infantile-onset ascending hereditary spastic paralysis,Deletion,genic downstream transcript variant|nonsense,2,201723335,,Pathogenic,N,-,rs386134187,201723335.0,ALS2,2,0.000744392716308142,0.0006313143127992866,0.0005764462334148376,0.0009623137187310868,0.0006381873781579475,0.0009137019384375518,22,24
rs1574698048,ALS2,Juvenile primary lateral sclerosis,single nucleotide variant,nonsense,2,201723371,G1195*,Pathogenic,G,T,rs1574698048,201723371.0,ALS2,2,0.0004263796172733849,0.0006583472112583137,0.0002954556314101789,0.00037228077547184717,0.0005109357981945577,0.00029487867003202725,12,15
rs2469758488,ALS2,Infantile-onset ascending hereditary spastic paralysis,Indel,frameshift variant,2,201723437 - 201723438,E1173fs,Likely pathogenic,N,-,rs2469758488,201723437.0,ALS2,2,0.0008241942316172528,0.0008448453790512124,0.0009241583706773336,0.0010432857410554385,0.0007038861438013857,0.0006047955235008938,24,24
rs1317051984,ALS2,Infantile-onset ascending hereditary spastic paralysis,Deletion,splice acceptor variant,2,201723437,,Pathogenic,G,-,rs1317051984,201723437.0,ALS2,2,0.0005671135662913415,0.00063915492869328,0.0006122511425184455,0.0005874761988911061,0.0006653535269315349,0.0003313320344223405,17,25
rs2105999102,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice acceptor variant,2,201723442,,Pathogenic,G,A,rs2105999102,201723442.0,ALS2,2,0.00026611812963269453,0.00032322989202126395,0.00033725785878446914,0.00018197383138249238,0.0003239604573010955,0.00016416860867415154,7,8
rs2469758597,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice acceptor variant,2,201723443,,Likely pathogenic,A,T,rs2469758597,201723443.0,ALS2,2,0.0008018466348278134,0.000942687423168977,0.0009628123245536373,0.0009038082089066667,0.0007319522961516947,0.0004679729213580906,24,34
rs2106001462,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice acceptor variant,2,201724460,,Likely pathogenic,G,A,rs2106001462,201724460.0,ALS2,2,0.0014350049184192173,0.0019472474542015547,0.00149067035065322,0.0013420083699904732,0.001429848038785003,0.0009652503784658358,42,42
rs2469768159,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice acceptor variant,2,201725456,,Likely pathogenic,A,T,rs2469768159,201725456.0,ALS2,2,0.0011851749064579753,0.0015084585491457556,0.0008853242432910122,0.0013637202164146235,0.0008541388254155867,0.001314232698022898,35,31
rs2106005949,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice donor variant,2,201726483,,Likely pathogenic,G,C,rs2106005949,201726483.0,ALS2,2,0.00045938009925945483,0.0005852561178993684,0.0004685209382159125,0.0004414225269788279,0.0004360086471813106,0.000365692266021855,13,11
rs2106005949,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice donor variant,2,201726483,,Likely pathogenic,G,T,rs2106005949,201726483.0,ALS2,2,0.0013361563769166281,0.001638105332625537,0.0015167392017567131,0.000978032568410023,0.0014436854542274448,0.0011042193275634228,40,51
rs2106005994,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,missense variant,2,201726511,G1074D,Pathogenic,G,A,rs2106005994,201726511.0,ALS2,2,0.0025345928614642264,0.0025432424364554037,0.001769945276373232,0.003132919179787042,0.00291797585632109,0.0023088815583843635,75,71
2:201726551,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice acceptor variant,2,201726551,,Likely pathogenic,A,G,2:201726551,201726551.0,ALS2,2,0.0005916583846650754,0.0006135072240121075,0.0005376509934528056,0.00045952057351441466,0.0008807742660410356,0.00046683886630501364,17,25
rs1691183538,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,missense variant,2,201726685,L1054P,Likely pathogenic,T,C,rs1691183538,201726685.0,ALS2,2,0.0016600469121246047,0.0019942334638766847,0.0016323765384768422,0.0008740411133885246,0.0019633560533736097,0.0018362273915073623,49,41
rs2469774653,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,nonsense,2,201726776,Q1024*,Pathogenic,C,T,rs2469774653,201726776.0,ALS2,2,0.0002999994671612347,0.0002945600033222842,0.00033872398029058593,0.00015951625066815763,0.00037524240450355166,0.00033195469702159406,8,11
rs2469780591,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,nonsense,2,201727737,W960*,Pathogenic,G,A,rs2469780591,201727737.0,ALS2,2,0.0009712233152758771,0.0013245526800066017,0.000758574135637104,0.0006410550501052437,0.001232493743983522,0.0008994409666469148,29,25
rs2106009582,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice acceptor variant,2,201727777,,Likely pathogenic,A,G,rs2106009582,201727777.0,ALS2,2,0.0007715950160613799,0.0007251796832876189,0.0008213325326370395,0.0005168643523887865,0.0010474943601702165,0.0007471041518232384,23,24
rs2469784078,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,nonsense,2,201728514,Q947*,Pathogenic,C,T,rs2469784078,201728514.0,ALS2,2,0.0001918681133997537,0.00024540958228535154,0.00019839837054432493,0.00017907468429748422,0.00018031759494796572,0.0001561403349236421,5,5
rs2106011709,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice acceptor variant,2,201728642,,Pathogenic,A,C,rs2106011709,201728642.0,ALS2,2,0.0007028668822373341,0.0009006978120304472,0.0005308831636506277,0.00039085884367133153,0.0008906144732408611,0.0008012801185934026,21,28
rs2106012637,ALS2,"Amyotrophic lateral sclerosis type 2, juvenile",Duplication,frameshift variant,2,201729056 - 201729057,M903fs,Pathogenic,N,NN,rs2106012637,201729056.0,ALS2,2,0.00026496123808233344,0.0003537444689486076,0.0002742843111971979,0.00023161521759116434,0.00015152450440485636,0.0003136376882698409,7,8
rs767762611,ALS2,ALS2-related disorder,Duplication,frameshift variant,2,201729063 - 201729064,G901fs,Likely pathogenic,N,NN,rs767762611,201729063.0,ALS2,2,0.0014827048910879051,0.0017649572881947024,0.0014155193570139953,0.0016063433666040246,0.001287363227519572,0.0013393412161072323,44,40
rs745657866,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,nonsense,2,201733329,R843*,Pathogenic,C,T,rs745657866,201733329.0,ALS2,2,0.000603820992867943,0.0006651897624127269,0.000594802763009785,0.0003664041950231834,0.0005564662412401709,0.0008362420026538484,18,16
rs1275973309,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice donor variant,2,201738669,,Pathogenic,G,C,rs1275973309,201738669.0,ALS2,2,0.0007106493015682767,0.0008817745684586973,0.0008606431284568103,0.000626080715707173,0.00047233615816026745,0.0007124119370584357,21,16
rs759408917,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,nonsense,2,201741804,R741*,Pathogenic,C,T,rs759408917,201741804.0,ALS2,2,0.00025442797722562604,0.00038724784892748204,0.0002733797395130932,0.0001484373650355573,0.0001966498239091173,0.00026642510874288035,7,7
rs2469852909,ALS2,"Amyotrophic lateral sclerosis type 2, juvenile",Duplication,frameshift variant,2,201744259 - 201744260,L723fs,Likely pathogenic,N,NN,rs2469852909,201744259.0,ALS2,2,0.000616530448669705,0.0005224103300169461,0.0007629318887070362,0.0007193086081535886,0.00042184168939088455,0.0006561597270800692,18,19
rs1574748038,ALS2,"Juvenile primary lateral sclerosis|Amyotrophic lateral sclerosis type 2, juvenile|Infantile-onset ascending hereditary spastic paralysis",single nucleotide variant,nonsense,2,201744324,E702*,Likely pathogenic,G,T,rs1574748038,201744324.0,ALS2,2,0.000261916858521592,0.0001971562498052845,0.00022593178023060323,0.00037109412321194725,0.00019116688091566712,0.00032423525844445776,7,4
rs1692492382,ALS2,Infantile-onset ascending hereditary spastic paralysis,Deletion,frameshift variant,2,201744402 - 201744412,V673fs,Pathogenic,N,-,rs1692492382,201744402.0,ALS2,2,0.0006322655187054375,0.0006981008963142391,0.0005150073977005178,0.00036784324726958276,0.0007677634192268613,0.0008126126330159863,18,17
rs1553511680,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,nonsense,2,201746643,Q641*,Pathogenic,C,T,rs1553511680,201746643.0,ALS2,2,0.00023090461773273672,0.00030741637781371686,0.0001973219325449241,0.0002360381916447281,0.00019117610299779718,0.00022257048366251727,6,4
rs863225294,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,nonsense,2,201746653,Y637*,Likely pathogenic,C,A,rs863225294,201746653.0,ALS2,2,0.0004934248734932418,0.00047188044857808867,0.0005863822497612841,0.0006294057485522623,0.0003981592244164218,0.000381296696158152,14,11
rs386134181,ALS2,Infantile-onset ascending hereditary spastic paralysis,Deletion,genic downstream transcript variant|frameshift variant,2,201746696 - 201746697,L623fs,Pathogenic,N,-,rs386134181,201746696.0,ALS2,2,0.00037082705345199403,0.00040135412383545885,0.00030808156129687875,0.0003821387594079752,0.00042170834177798186,0.00034085248094167564,11,15
rs1060503672,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice acceptor variant,2,201746749,,Likely pathogenic,G,A,rs1060503672,201746749.0,ALS2,2,0.00045451295754590277,0.0004999961383061176,0.0005228778343888403,0.00023780515868454554,0.00040024881835383947,0.0006116368379961708,13,12
rs2106074302,ALS2,Infantile-onset ascending hereditary spastic paralysis,Deletion,frameshift variant,2,201754521,H541fs,Pathogenic,N,-,rs2106074302,201754521.0,ALS2,2,0.0005255964817008674,0.0004513193921703617,0.0005917196945041264,0.0005391595732434892,0.00068524292785346,0.000360540820732899,15,22
2:201754609 - 201754610,ALS2,Infantile-onset ascending hereditary spastic paralysis,Duplication,frameshift variant,2,201754609 - 201754610,T512fs,Pathogenic,N,NN,2:201754609 - 201754610,201754609.0,ALS2,2,0.000931685002634967,0.001370964317864157,0.0006826888096940027,0.001116936642169121,0.0005757111562375368,0.0009121240872100177,27,27
rs1693462968,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice donor variant,2,201757401,,Likely pathogenic,G,A,rs1693462968,201757401.0,ALS2,2,0.0005204971217443648,0.0007338771434619361,0.0004775706061551469,0.00031645067654641695,0.0005936922882257338,0.0004808948943325907,15,14
rs878855058,ALS2,Infantile-onset ascending hereditary spastic paralysis,Deletion,frameshift variant,2,201757445 - 201757448,G477fs,Pathogenic,N,-,rs878855058,201757445.0,ALS2,2,0.0006843005762840781,0.0010668337139549846,0.0006134837840447894,0.000481441119449501,0.0007008312270658443,0.0005589130369052711,20,18
rs2469899610,ALS2,"Juvenile primary lateral sclerosis|Amyotrophic lateral sclerosis type 2, juvenile|Infantile-onset ascending hereditary spastic paralysis",Deletion,frameshift variant,2,201757546 - 201757552,I441fs,Likely pathogenic,N,-,rs2469899610,201757546.0,ALS2,2,0.0011037710856739284,0.0009481336983689705,0.0011718565528563828,0.0012593240745112863,0.0012283316852378429,0.0009112094173951589,33,32
2:201757623,ALS2,"Amyotrophic lateral sclerosis type 2, juvenile",single nucleotide variant,nonsense,2,201757623,S417*,Pathogenic,C,G,2:201757623,201757623.0,ALS2,2,0.0007840842747451525,0.001015585679747254,0.0006462893417537944,0.0004041799980203551,0.0008780385652445705,0.0009763277889597885,23,20
rs2469900041,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,nonsense,2,201757623,S417*,Likely pathogenic,C,A,rs2469900041,201757623.0,ALS2,2,0.0009250641212429154,0.0011209638240042884,0.0005701891984370548,0.00082477811547094,0.0010309028328107568,0.0010784866354915375,27,22
rs2106080813,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,splice acceptor variant,2,201757760,,Likely pathogenic,G,A,rs2106080813,201757760.0,ALS2,2,0.0012877572444986575,0.00131758747458822,0.0016563346385220718,0.0005891036552314055,0.0014872579942933246,0.0013885024598582658,38,39
2:201760880,ALS2,Infantile-onset ascending hereditary spastic paralysis,Deletion,frameshift variant|splice donor variant,2,201760880,V372fs,Pathogenic,N,-,2:201760880,201760880.0,ALS2,2,0.00042883948068551497,0.0005615803194385582,0.0003404952628729526,0.00041456310760453445,0.0004956165682283246,0.00033194214528320485,12,15
rs1693726956,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,nonsense,2,201760950,Y348*,Pathogenic,C,G,rs1693726956,201760950.0,ALS2,2,0.0007271913840541083,0.000881721638748477,0.000702366048660049,0.0008353419694537663,0.0005959997241845068,0.0006205275392237422,21,27
rs386134175,ALS2,Infantile-onset ascending hereditary spastic paralysis,Deletion,frameshift variant,2,201760986 - 201760987,I336fs,Pathogenic,N,-,rs386134175,201760986.0,ALS2,2,0.0010099446650811885,0.0015148019516796406,0.0010758684700420407,0.0007572482149484772,0.0010023044303918015,0.0006995002583439817,30,28
rs2469913984,ALS2,Infantile-onset ascending hereditary spastic paralysis,Deletion,frameshift variant,2,201761017,G326fs,Pathogenic,N,-,rs2469913984,201761017.0,ALS2,2,0.0009485201020932775,0.0012373030525564045,0.001244098917685507,0.00047343916799335293,0.0011076599977798156,0.0006800993744513075,28,28
rs1574786641,ALS2,Infantile-onset ascending hereditary spastic paralysis,Deletion,nonsense,2,201761081,,Pathogenic,N,-,rs1574786641,201761081.0,ALS2,2,6.039795900362106e-05,5.392549465945187e-05,7.890257933738678e-05,6.49153004014461e-05,4.231803391468467e-05,6.19283867051359e-05,1,4
rs2106088185,ALS2,Infantile-onset ascending hereditary spastic paralysis,Deletion,frameshift variant,2,201761130,V289fs,Pathogenic,N,-,rs2106088185,201761130.0,ALS2,2,0.0005967554536863734,0.0006940316734072348,0.0005565298104550251,0.0006244098207151424,0.0005651936895103106,0.0005436122743441544,17,20
rs767032589,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,nonsense,2,201761353,L214*,Pathogenic,T,G,rs767032589,201761353.0,ALS2,2,0.00021104646989626545,0.000307938527198445,0.00020793328465958786,0.0001797520360540609,0.00021872810178894463,0.00014088039978028878,6,7
rs386134174,ALS2,Juvenile primary lateral sclerosis,Deletion,frameshift variant,2,201761441,T185fs,Pathogenic,N,-,rs386134174,201761441.0,ALS2,2,0.0009034446015754136,0.001176063774102385,0.0010709313812202067,0.0005212349882138582,0.0006887209167819368,0.0010602719475586817,27,23
rs2469917312,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,nonsense,2,201761534,Q154*,Pathogenic,C,T,rs2469917312,201761534.0,ALS2,2,0.00021241291929916884,0.00018525900486063214,0.00022962960378272777,0.0001426018918471617,0.0002724808475310283,0.00023209324847429434,6,4
rs2106089689,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,missense variant,2,201761647,G116E,Pathogenic,G,A,rs2106089689,201761647.0,ALS2,2,0.0026222675773648857,0.003331760047033863,0.0023020502822411124,0.0014640461689140463,0.003127318126022071,0.0028861632626133358,78,86
rs2106089798,ALS2,Infantile-onset ascending hereditary spastic paralysis,Deletion,frameshift variant,2,201761668,N109fs,Pathogenic,N,-,rs2106089798,201761668.0,ALS2,2,0.00013413075139945388,0.00020825437876209003,0.00016095349655430603,0.00010014135949950142,9.118276250008123e-05,0.00011012175968129077,4,3
rs1693780539,ALS2,Juvenile primary lateral sclerosis,Microsatellite,frameshift variant,2,201761718 - 201761719,Y92fs,Pathogenic,N,-,rs1693780539,201761718.0,ALS2,2,0.00033679471355338447,0.00029104278053540983,0.00033629139287258327,0.0003626948672974738,0.00046809650667969347,0.0002258480203817618,10,3
rs2106102271,ALS2,Infantile-onset ascending hereditary spastic paralysis,Deletion,inframe_deletion,2,201767244 - 201767246,G53del,Pathogenic,N,-,rs2106102271,201767244.0,ALS2,2,0.001915042940594322,0.002059061355010985,0.002129007035250548,0.0010715743841344053,0.0022933109061382033,0.0020222610224374686,57,57
2:201767259,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,missense variant,2,201767259,G49R,Pathogenic,G,A,2:201767259,201767259.0,ALS2,2,0.0011968855142813367,0.0013427993467387766,0.0008999183451349863,0.0012928951310849635,0.001583573284198008,0.0008652414642499484,35,29
rs2469943073,ALS2,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,nonsense,2,201767290,W38*,Pathogenic,G,A,rs2469943073,201767290.0,ALS2,2,0.0002855343015296502,0.0002819407567939258,0.0003384097369923353,0.0003107867695954722,0.00029879281651192224,0.00019774142775459545,8,6
rs371332509,ERBB4,Amyotrophic lateral sclerosis,single nucleotide variant,missense variant,2,211383728,"G1256R, G1272R",Likely pathogenic,G,A,rs371332509,211383728.0,ERBB4,2,0.002898832945832262,0.002730872839405443,0.00300491478973534,0.002850097514314503,0.0035016174929397635,0.00240666209276626,86,87
2:211387943,ERBB4,Amyotrophic lateral sclerosis type 19,single nucleotide variant,intron variant|splice donor variant,2,211387943,,Likely pathogenic,T,C,2:211387943,211387943.0,ERBB4,2,0.0012711301696846683,0.0018182953438207225,0.0011041954705227654,0.0008887696153836187,0.0015879237686955221,0.0009564666500007127,38,42
rs368743618,TUBA4A,Amyotrophic lateral sclerosis type 22,single nucleotide variant,missense variant,2,219250552,"A383T, A368T",Likely pathogenic,G,A,rs368743618,219250552.0,TUBA4A,2,0.0030317421018689885,0.003975303130468994,0.002779574353821001,0.0023913292920791744,0.0030643145352243772,0.002948189197751396,90,92
3:87253797,CHMP2B,Frontotemporal dementia and/or amyotrophic lateral sclerosis 7,single nucleotide variant,missense variant,3,87253797,"Q165P, Q206P, Q238P",Likely pathogenic,A,C,3:87253797,87253797.0,CHMP2B,3,0.004946339803856085,0.004483574720331167,0.0060334140853578674,0.005181595547097136,0.0041331584766468085,0.004899956189847444,147,148
4:169438207,NEK1,"Short-rib thoracic dysplasia 6 with or without polydactyly|Amyotrophic lateral sclerosis, susceptibility to, 24",Deletion,frameshift variant|non-coding transcript variant|intron variant,4,169438207,"V784fs, V809fs, V836fs, V837fs, V853fs, V881fs",Likely pathogenic,N,-,4:169438207,169438207.0,NEK1,4,0.0009594582791186107,0.0007585361642368215,0.000793591686543701,0.0011499531841414725,0.0011204922210995513,0.0009747181395715074,28,38
rs1744312712,NEK1,Short-rib thoracic dysplasia 6 with or without polydactyly,single nucleotide variant,nonsense|non-coding transcript variant,4,169463291,"E745*, E750*, E775*, E802*, E803*, E819*, E847*",Likely pathogenic,G,T,rs1744312712,169463291.0,NEK1,4,0.00017133024736024392,0.00019835359562855756,0.00022665401370783165,8.87770202849164e-05,0.00018142674097163046,0.00016143986620828355,5,3
rs750159428,NEK1,"Amyotrophic lateral sclerosis, susceptibility to, 24",Microsatellite,nonsense|non-coding transcript variant,4,169477275 - 169477276,,Likely pathogenic,N,-,rs750159428,169477275.0,NEK1,4,0.0011440626635228902,0.0012732705037335921,0.0007827301473136797,0.0011573522425160586,0.0011726636177485724,0.0013342968063025488,34,29
rs2546553407,NEK1,"Amyotrophic lateral sclerosis, susceptibility to, 24",single nucleotide variant,nonsense|non-coding transcript variant,4,169508277,"Q505*, Q530*, Q532*, Q557*, Q558*, Q574*, Q602*",Likely pathogenic,C,T,rs2546553407,169508277.0,NEK1,4,0.0002743826758374849,0.0003709773306506984,0.00019443620130796905,0.00029787894311602333,0.0002446882670055155,0.00026393263710721825,8,13
4:169508778 - 169508779,NEK1,"Amyotrophic lateral sclerosis, susceptibility to, 24",Deletion,frameshift variant|intron variant,4,169508778 - 169508779,"K536fs, K580fs",Likely pathogenic,N,-,4:169508778 - 169508779,169508778.0,NEK1,4,0.0007173398903604456,0.0007599029784892522,0.000802542749873995,0.0005498101897658126,0.0008463887499407137,0.0006280547837324543,21,23
rs371575563,NEK1,Short-rib thoracic dysplasia 6 with or without polydactyly,single nucleotide variant,nonsense|non-coding transcript variant,4,169537826,"R550*, R506*, R481*, R508*, R533*",Pathogenic,C,T,rs371575563,169537826.0,NEK1,4,0.00017218876112560323,0.00020376953645056693,0.00011913827816068521,0.00020519189733737115,0.00021974303574115887,0.000113101057938234,5,2
rs969452649,NEK1,"Amyotrophic lateral sclerosis, susceptibility to, 24",single nucleotide variant,nonsense|non-coding transcript variant,4,169555948,"R430*, R447*, R455*, R472*",Likely pathogenic,C,T,rs969452649,169555948.0,NEK1,4,0.0010898836644260804,0.0014563142888154694,0.0011292410579467997,0.0007975403095394687,0.0009046675746509647,0.0011616550911776997,32,28
rs2546764617,NEK1,"Amyotrophic lateral sclerosis, susceptibility to, 24",single nucleotide variant,nonsense|non-coding transcript variant,4,169556038,"Q400*, Q417*, Q425*, Q442*",Likely pathogenic,C,T,rs2546764617,169556038.0,NEK1,4,0.0002438830143027934,0.0002700886091969108,0.00019954973424529438,0.0002141394029337298,0.0002388194138868964,0.00029681791125113553,7,6
4:169556044,NEK1,Short-rib thoracic dysplasia 6 with or without polydactyly,single nucleotide variant,nonsense|non-coding transcript variant,4,169556044,"R398*, R440*, R423*, R415*",Pathogenic,C,T,4:169556044,169556044.0,NEK1,4,0.00014494169314286832,0.00016264288521016472,0.00015095359116370805,0.00013747137174187704,0.00017226774184367865,0.00010137287575491316,4,5
rs370576859,NEK1,Short-rib thoracic dysplasia 6 with or without polydactyly,single nucleotide variant,splice donor variant,4,169587558,,Likely pathogenic,G,C,rs370576859,169587558.0,NEK1,4,0.0005088075647280404,0.0004517707614347534,0.0004908586488815531,0.0004787437177402988,0.0007304102795199687,0.0003922544160636278,15,19
rs2480199584,LOC129995449|SQSTM1,"Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1",Indel,intron variant|splice donor variant,5,179821121 - 179821189,,Likely pathogenic,N,-,rs2480199584,179821121.0,LOC129995449,5,0.0007664841301640709,0.0010544144131038812,0.0005563637245955013,0.0006160270171469839,0.0007340830029038357,0.000871532493070153,22,24
rs1757759029,LOC129995449|SQSTM1,"Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Paget disease of bone 2, early-onset",single nucleotide variant,intron variant|splice donor variant,5,179821143,,Likely pathogenic,T,C,rs1757759029,179821143.0,LOC129995449,5,0.0005374543059041483,0.0006601607017285463,0.0004858964331915835,0.0005518513708090107,0.0003708985422539855,0.0006184644815376153,16,10
rs373306317,SQSTM1,"Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1",single nucleotide variant,splice acceptor variant,5,179822956,,Likely pathogenic,A,G,rs373306317,179822956.0,SQSTM1,5,0.0006141941008973637,0.0007351484081448855,0.0006410924112662494,0.0004253527795315546,0.0006599394022261521,0.0006094375033179767,18,16
5:179822957,SQSTM1,"Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1",single nucleotide variant,splice acceptor variant,5,179822957,,Likely pathogenic,G,C,5:179822957,179822957.0,SQSTM1,5,0.0005587049291320036,0.0007420432944677324,0.00041402975779402523,0.00038198323538765817,0.00047441540159737504,0.000781052956413227,16,20
rs1425863340,SQSTM1,"Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1",single nucleotide variant,5 prime UTR variant|nonsense,5,179822996,E82*,Pathogenic,G,T,rs1425863340,179822996.0,SQSTM1,5,0.00017177634119503417,0.0002172823252526687,0.00019871200568456117,9.138748199317601e-05,0.00015143208069042004,0.00020006781235434501,5,4
rs2480208932,SQSTM1,"Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Paget disease of bone 2, early-onset",Insertion,frameshift variant,5,179823011 - 179823012,"M3fs, M87fs",Pathogenic,-,ATGCCTTTTCCAGTGACGAGGAATTGACGAGGAAT,rs2480208932,179823011.0,SQSTM1,5,0.0009803965229607692,0.0010464843744781363,0.0006747173916546151,0.0009929969609056707,0.001075289313290309,0.001112494574475115,29,32
rs1008679317,SQSTM1,"Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1",Duplication,frameshift variant,5,179823859 - 179823860,"E104fs, E20fs",Pathogenic,N,NN,rs1008679317,179823859.0,SQSTM1,5,0.00046370932894851033,0.000352312251614063,0.0003613795190605193,0.0005430048753396905,0.0006892086061689028,0.00037264139255937617,13,11
5:179824221,SQSTM1,"Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1",single nucleotide variant,nonsense,5,179824221,"G107*, G191*",Pathogenic,G,T,5:179824221,179824221.0,SQSTM1,5,0.00012677832770489937,0.00016628548466597205,8.055103850478115e-05,9.176087189883165e-05,0.0001640594566484692,0.00013123478680644287,3,10
5:179824266 - 179824267,SQSTM1,"Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1",Deletion,frameshift variant,5,179824266 - 179824267,"W122fs, W206fs",Pathogenic,N,-,5:179824266 - 179824267,179824266.0,SQSTM1,5,0.00019127578686340272,0.0001975955030427239,0.00016467128888769038,0.00020639856539626786,0.0002107058885105787,0.00017700768847975288,5,7
5:179825158,SQSTM1,"Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1",single nucleotide variant,nonsense,5,179825158,"S145*, S229*",Pathogenic,C,A,5:179825158,179825158.0,SQSTM1,5,0.0006765896099705438,0.0006109223356675128,0.0007118562756571183,0.0009367459171448487,0.0006007768215201039,0.0005226466998631353,20,20
rs2480243842,SQSTM1,"Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Paget disease of bone 2, early-onset",Duplication,frameshift variant,5,179833039 - 179833040,"V171fs, V255fs",Pathogenic,N,NN,rs2480243842,179833039.0,SQSTM1,5,0.00010074053737502684,0.0001339221667787971,9.579157047166488e-05,8.089579118794048e-05,9.828688433288084e-05,9.480627410385088e-05,3,3
rs1758316662,SQSTM1,"Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Paget disease of bone 2, early-onset",Deletion,frameshift variant,5,179833083,"V187fs, V271fs",Pathogenic,N,-,rs1758316662,179833083.0,SQSTM1,5,0.0007318784340340198,0.0005596736851693553,0.000747309340536011,0.0006025252899051346,0.0007605240915624741,0.0009893597629971238,21,11
rs2480244186,SQSTM1,"Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Paget disease of bone 2, early-onset",Deletion,nonsense,5,179833092 - 179833095,,Pathogenic,N,-,rs2480244186,179833092.0,SQSTM1,5,0.0008986435930686697,0.0010111430150892217,0.0007031890285642813,0.0008158065444160716,0.0011050365691900907,0.0008580428080836838,26,26
rs2480244231,SQSTM1,"Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Paget disease of bone 2, early-onset",single nucleotide variant,nonsense,5,179833097,"E190*, E274*",Pathogenic,G,T,rs2480244231,179833097.0,SQSTM1,5,0.0007093519575043479,0.0008894164843640149,0.0006398294999470269,0.0005783905396223238,0.0008185149784028259,0.0006206082851855481,21,16
rs1258386028,SQSTM1,"Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1",single nucleotide variant,nonsense,5,179833178,"E217*, E301*",Pathogenic,G,T,rs1258386028,179833178.0,SQSTM1,5,0.0008736251375123718,0.0010261960346383782,0.000696842680277752,0.0008413574234373123,0.0005709734541764749,0.0012327560950319415,26,26
rs2113512370,SQSTM1,"Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Paget disease of bone 2, early-onset",single nucleotide variant,splice acceptor variant,5,179833585,,Likely pathogenic,A,G,rs2113512370,179833585.0,SQSTM1,5,0.0010333947868741559,0.001326176277882829,0.0009220075888396392,0.0009666423301528656,0.0009881626224602764,0.0009639851150351694,30,24
rs1758351897,SQSTM1,"Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1",single nucleotide variant,nonsense,5,179833590,"Q241*, Q325*",Pathogenic,C,T,rs1758351897,179833590.0,SQSTM1,5,0.0005370429640488929,0.0007824062343840004,0.0006095150816339594,0.0003596903992035122,0.0003892575395005395,0.000544345565522453,16,22
rs2113512406,SQSTM1,"Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Paget disease of bone 2, early-onset",Duplication,frameshift variant,5,179833594 - 179833595,"E327fs, E243fs",Pathogenic,N,NN,rs2113512406,179833594.0,SQSTM1,5,9.219192329078184e-05,9.248359200567558e-05,7.9820581402703e-05,7.974317050449285e-05,9.657250297209019e-05,0.00011233976956894764,2,3
rs1185406298,SQSTM1,"Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1",single nucleotide variant,nonsense,5,179833612,"S248*, S332*",Pathogenic,C,G,rs1185406298,179833612.0,SQSTM1,5,0.0007371968267110881,0.0009651870830923678,0.0009878870517403913,0.0006151680063792088,0.0005740745474673601,0.0005436674448761126,22,22
rs1261101487,SQSTM1,"Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1",single nucleotide variant,nonsense,5,179833728,"Q287*, Q371*",Pathogenic,C,T,rs1261101487,179833728.0,SQSTM1,5,0.00018326853963263257,0.00019853348441539127,0.00018647757984626657,0.0001396228155292541,0.00014377886127382014,0.00024792995709843065,5,6
rs1758359961,SQSTM1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 3,Deletion,frameshift variant,5,179833743,,Likely pathogenic,N,-,rs1758359961,179833743.0,SQSTM1,5,0.0008740563611544915,0.0009790292938875531,0.0010355914246413466,0.0009925285555479368,0.0006251979199957925,0.0007379346116998284,26,27
5:179833760 - 179833761,SQSTM1,"Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1",Duplication,frameshift variant,5,179833760 - 179833761,"L298fs, L382fs",Likely pathogenic,N,NN,5:179833760 - 179833761,179833760.0,SQSTM1,5,0.0001871293460290135,0.00025175760573252184,0.0002215489928388304,0.00013958014686408607,0.00020424339246799956,0.00011851659224162971,5,4
5:179833778 - 179833779,SQSTM1,"Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1",Duplication,frameshift variant,5,179833778 - 179833779,"E305fs, E389fs",Likely pathogenic,N,NN,5:179833778 - 179833779,179833778.0,SQSTM1,5,0.0012388492019198359,0.001171848659068812,0.000897356272407101,0.0012396246059769218,0.0015961770355873268,0.0012892394365590185,37,34
rs1391182750,SQSTM1,"Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1",single nucleotide variant,missense variant,5,179833782,"E305Q, E389Q",Pathogenic,G,C,rs1391182750,179833782.0,SQSTM1,5,0.002707149088564064,0.005050955154800205,0.0024518983371283813,0.0016679917033394652,0.001893822185189275,0.0024710780623629913,80,86
rs796051870,SQSTM1,"Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Paget disease of bone 2, early-onset",single nucleotide variant,splice donor variant,5,179833783,,Pathogenic,G,A,rs796051870,179833783.0,SQSTM1,5,0.00041944663070441065,0.00038222145033451547,0.0004479782928458621,0.00039992742938552275,0.0005624536463286798,0.00030465233462747323,12,15
rs2480264715,SQSTM1,"Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Paget disease of bone 2, early-onset",Deletion,frameshift variant,5,179836443,"P392fs, P308fs",Pathogenic,N,-,rs2480264715,179836443.0,SQSTM1,5,0.0007785157701990222,0.0011220192786881528,0.0006106107730540053,0.00040328623072917984,0.0006732831492355082,0.0010833794192882651,23,25
5:179836448 - 179837234,SQSTM1|LOC112997583,"Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1",Deletion,frameshift variant,5,179836448 - 179837234,"L310fs, L394fs",Likely pathogenic,N,-,5:179836448 - 179837234,179836448.0,SQSTM1,5,0.0004992822905199583,0.0006238534173124134,0.00030957806376182077,0.0005813118342658843,0.0005709187090582433,0.00041074942820143006,14,17
rs1254158201,SQSTM1,"Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Paget disease of bone 2, early-onset",Duplication,nonsense,5,179836453 - 179836454,"E312*, E396*",Pathogenic,N,NN,rs1254158201,179836453.0,SQSTM1,5,0.0011330974067370267,0.0011351800701097001,0.000682538398592552,0.0011332838862849806,0.0013568146433280141,0.0013576700353698861,33,37
rs1247551175,SQSTM1,"Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Paget disease of bone 2, early-onset",single nucleotide variant,missense variant,5,179836481,"M320T, M404T",Pathogenic,T,C,rs1247551175,179836481.0,SQSTM1,5,0.0024172363218442684,0.003224534815652771,0.0016542637334042028,0.0023190018080343463,0.001966121854723749,0.0029222593974062732,72,75
rs753207473,FIG4,Charcot-Marie-Tooth disease type 4,single nucleotide variant,nonsense,6,109716541,R88*,Pathogenic,C,T,rs753207473,109716541.0,FIG4,6,0.0008375957291643775,0.0008666573397607983,0.0007538589255372377,0.0010237649179273586,0.0008941267361770028,0.0006495707264194896,25,23
rs2486126464,FIG4,Amyotrophic lateral sclerosis type 11,Duplication,splice acceptor variant,6,109738323 - 109738324,,Likely pathogenic,-,G,rs2486126464,109738323.0,FIG4,6,0.0010114156889412008,0.0008965994312471502,0.001214076139763563,0.0010101209926533946,0.0010248561005219699,0.0009114257805199265,30,21
rs1583695322,FIG4,Charcot-Marie-Tooth disease,Deletion,frameshift variant,6,109760259,R384fs,Likely pathogenic,N,-,rs1583695322,109760259.0,FIG4,6,0.0004918080750381203,0.0005740904043290943,0.00045881177228314926,0.00046133499544617675,0.00046625657175455024,0.0004985466313776309,14,12
6:109760262,FIG4,Yunis-Varon syndrome|Bilateral parasagittal parieto-occipital polymicrogyria|Amyotrophic lateral sclerosis type 11|Charcot-Marie-Tooth disease type 4J,single nucleotide variant,nonsense,6,109760262,R384*,Likely pathogenic,A,T,6:109760262,109760262.0,FIG4,6,0.001347310971328957,0.0016666531685932669,0.0015657485697079148,0.001422725648912634,0.0010783478119732698,0.0010030796574576999,40,43
6:109763935,FIG4,Charcot-Marie-Tooth disease type 4J|Bilateral parasagittal parieto-occipital polymicrogyria|Amyotrophic lateral sclerosis type 11|Yunis-Varon syndrome,single nucleotide variant,splice acceptor variant,6,109763935,,Likely pathogenic,A,G,6:109763935,109763935.0,FIG4,6,0.0004440335589843262,0.0007274427046784942,0.00032894437254283465,0.0002989474762836277,0.00040251689030932643,0.00046231635110734805,13,14
rs756308787,FIG4,Yunis-Varon syndrome,single nucleotide variant,splice donor variant,6,109791573,,Likely pathogenic,T,G,rs756308787,109791573.0,FIG4,6,0.0006652676614544963,0.000709289894530444,0.0006738941223701468,0.0006454086097442607,0.0006052396177793392,0.0006925060628482908,19,23
rs2076486420,SYNE1,Juvenile amyotrophic lateral sclerosis,single nucleotide variant,nonsense,6,152206257,"Q7573*, Q7644*",Pathogenic,C,T,rs2076486420,152206257.0,SYNE1,6,0.0008404556119080397,0.0010374821004825356,0.0007607369583322874,0.0005983225341122664,0.0007074249121036225,0.0010983115545094865,25,23
rs2128109836,HNRNPA2B1,Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2,single nucleotide variant,missense variant,7,26193322,"P310L, P298L",Likely pathogenic,C,T,rs2128109836,26193322.0,HNRNPA2B1,7,0.00254004321586479,0.0032383267613680902,0.0036229072836201854,0.0014312475774813913,0.0025608498232270343,0.0018468846336272505,76,78
9:27573529 - 27573534,C9orf72|LOC109504728|LOC129929032,Amyotrophic lateral sclerosis,Microsatellite,,9,27573529 - 27573534,,Pathogenic,,,9:27573529 - 27573534,27573529.0,C9orf72,9,0.00012085779640156076,0.00012429222987514775,0.00013561550040699208,7.95391340718173e-05,0.0001466659592740318,0.00011817615837981485,3,4
rs1554707622,SIGMAR1,Amyotrophic lateral sclerosis type 16,Deletion,splice acceptor variant,9,34635592 - 34635883,,Likely pathogenic,N,-,rs1554707622,34635592.0,SIGMAR1,9,0.000901377651840444,0.0010811218725401638,0.0006203296727884462,0.0012891883663198628,0.0008781069536716527,0.0006381413938820947,27,24
9:34635632,SIGMAR1,Amyotrophic lateral sclerosis type 16,single nucleotide variant,missense variant|stop lost|3 prime UTR variant|non-coding transcript variant,9,34635632,T152A,Likely pathogenic,A,G,9:34635632,34635632.0,SIGMAR1,9,0.001055686432228327,0.0010986632993797466,0.0015449767382785327,0.0006841624171925234,0.0011283868903743629,0.0008222428159164695,31,35
rs2132323906,SIGMAR1,Amyotrophic lateral sclerosis type 16,single nucleotide variant,missense variant|3 prime UTR variant|non-coding transcript variant|intron variant,9,34635667,"E113K, E182K, E193K, E213K",Likely pathogenic,G,A,rs2132323906,34635667.0,SIGMAR1,9,0.0036137148073948286,0.004478521095137898,0.0041415929092565,0.0022668400823745894,0.0038792300887463883,0.003302389861458769,108,99
rs1242817438,SIGMAR1,Autosomal recessive distal spinal muscular atrophy 2|Amyotrophic lateral sclerosis type 16,single nucleotide variant,nonsense|3 prime UTR variant|non-coding transcript variant|intron variant,9,34635812,"W133*, W144*, W164*, W64*",Pathogenic,G,A,rs1242817438,34635812.0,SIGMAR1,9,0.00026457592257635284,0.00035486399198538226,0.0002329115166858785,0.00013038580269745647,0.00031407905836452224,0.00029063924314852484,7,6
rs2492811707,SIGMAR1,Autosomal recessive distal spinal muscular atrophy 2|Amyotrophic lateral sclerosis type 16,Deletion,frameshift variant|non-coding transcript variant|intron variant,9,34635833 - 34635848,"V153fs, V122fs, V133fs, V53fs, S106fs",Pathogenic,N,-,rs2492811707,34635833.0,SIGMAR1,9,0.0004611961907615568,0.0004747453591532141,0.0005331759258598444,0.0004243807922156963,0.0004437354758870144,0.0004299434006920148,13,13
rs1820836522,SIGMAR1,Amyotrophic lateral sclerosis type 16,single nucleotide variant,missense variant|synonymous variant|non-coding transcript variant|intron variant,9,34635853,"T51A, D104G, T151A, T120A, T131A",Likely pathogenic,A,G,rs1820836522,34635853.0,SIGMAR1,9,0.0031238349546246886,0.003747947831009019,0.0025083089201023423,0.002975128450432879,0.0031521301153647255,0.0032356594562144756,93,85
9:34636996,SIGMAR1,Autosomal recessive distal spinal muscular atrophy 2|Amyotrophic lateral sclerosis type 16,single nucleotide variant,splice donor variant|intron variant,9,34636996,,Pathogenic,G,A,9:34636996,34636996.0,SIGMAR1,9,0.0007386818298375853,0.0006759264665014217,0.0008714191798249868,0.0006922383086893485,0.0007349642953076776,0.0007188608988644926,22,20
9:34637039,SIGMAR1,Amyotrophic lateral sclerosis type 16|Autosomal recessive distal spinal muscular atrophy 2,single nucleotide variant,nonsense|synonymous variant|non-coding transcript variant|intron variant,9,34637039,"Q115*, Q135*, Q35*",Pathogenic,C,T,9:34637039,34637039.0,SIGMAR1,9,0.000465533940611632,0.0004708918978603904,0.0005391201945893023,0.0004953001840259608,0.0005551358216580828,0.00026722160492442354,13,18
rs755994483,SIGMAR1,Autosomal recessive distal spinal muscular atrophy 2|Amyotrophic lateral sclerosis type 16,single nucleotide variant,nonsense|synonymous variant|non-coding transcript variant|intron variant,9,34637068,"S105*, S125*, S25*",Pathogenic,C,A,rs755994483,34637068.0,SIGMAR1,9,0.00044165758592181885,0.0003362383583840589,0.0006056293632140477,0.000476973908829605,0.0005160759432433926,0.00027337035593799,13,14
9:34637352 - 34637355,SIGMAR1,Amyotrophic lateral sclerosis type 16|Autosomal recessive distal spinal muscular atrophy 2,Deletion,frameshift variant|5 prime UTR variant|non-coding transcript variant,9,34637352 - 34637355,"V53fs, V73fs",Pathogenic,N,-,9:34637352 - 34637355,34637352.0,SIGMAR1,9,0.0008224638976497889,0.000770417770070075,0.0008364560697455405,0.0008063282424908291,0.0009774593280895488,0.0007216580778529512,24,25
rs2132329744,SIGMAR1,Autosomal recessive distal spinal muscular atrophy 2|Amyotrophic lateral sclerosis type 16,single nucleotide variant,splice acceptor variant,9,34637422,,Likely pathogenic,A,T,rs2132329744,34637422.0,SIGMAR1,9,0.0002516310671023361,0.00021199794552455555,0.00031526099083540985,0.00029153150616484337,0.00017954652256222092,0.00025981837042465074,7,6
rs2492828821,LOC130001681|SIGMAR1,Autosomal recessive distal spinal muscular atrophy 2|Amyotrophic lateral sclerosis type 16,Deletion,frameshift variant|5 prime UTR variant|non-coding transcript variant|intron variant,9,34637572 - 34637573,I42fs,Pathogenic,N,-,rs2492828821,34637572.0,LOC130001681,9,0.00018258243526868468,0.00018292530166780132,0.00022957912332704038,0.0001370192602365974,0.0002497232770840163,0.00011366521402796805,5,1
9:34637588 - 34637589,SIGMAR1|LOC130001681,Amyotrophic lateral sclerosis type 16|Autosomal recessive distal spinal muscular atrophy 2,Deletion,frameshift variant|5 prime UTR variant|non-coding transcript variant|intron variant,9,34637588 - 34637589,F37fs,Likely pathogenic,N,-,9:34637588 - 34637589,34637588.0,SIGMAR1,9,0.0013698968976180964,0.001197970383013215,0.0012525356021828836,0.001213497105454808,0.0015137480536716187,0.0016717333437679558,41,33
rs1449250083,LOC130001681|SIGMAR1,Amyotrophic lateral sclerosis type 16|Autosomal recessive distal spinal muscular atrophy 2,single nucleotide variant,nonsense|5 prime UTR variant|non-coding transcript variant,9,34637612,W29*,Pathogenic,G,A,rs1449250083,34637612.0,LOC130001681,9,9.534274597914388e-05,0.00012756632723574774,0.00010187620337097894,9.479963416257908e-05,6.107431123338877e-05,9.139725389302481e-05,2,1
9:34637625,LOC130001681|SIGMAR1,Amyotrophic lateral sclerosis type 16,Deletion,frameshift variant|5 prime UTR variant|non-coding transcript variant,9,34637625,V25fs,Likely pathogenic,N,-,9:34637625,34637625.0,LOC130001681,9,0.001178457783157282,0.0015415989334281654,0.001143065955200818,0.0009385347377332463,0.0011477888042861332,0.0011213004851380476,35,42
rs1564096761,LOC130001681|SIGMAR1,Autosomal recessive distal spinal muscular atrophy 2|Amyotrophic lateral sclerosis type 16,Deletion,frameshift variant|5 prime UTR variant|non-coding transcript variant,9,34637685,V5fs,Pathogenic,N,-,rs1564096761,34637685.0,LOC130001681,9,0.0006164318090686258,0.0005502194966743568,0.0006926226793579945,0.0005297700499292819,0.0006964456997941605,0.000613101119587335,18,12
rs1828783140,VCP,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6,single nucleotide variant,missense variant,9,35064214,"I171M, I216M",Likely pathogenic,A,G,rs1828783140,35064214.0,VCP,9,0.0008384309236519926,0.0013009935576870262,0.0008106394411663627,0.000496211049471549,0.0006298873398636553,0.0009544232300713694,25,26
rs1828784075,VCP,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6,single nucleotide variant,splice acceptor variant,9,35064287,,Likely pathogenic,A,G,rs1828784075,35064287.0,VCP,9,0.0007213782767448846,0.0008332405053273864,0.0007411286339467112,0.0005668047390521826,0.0007928862611779011,0.0006728312442202419,21,16
9:35065264,VCP,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1,single nucleotide variant,missense variant,9,35065264,"P143H, P188H",Likely pathogenic,C,A,9:35065264,35065264.0,VCP,9,0.0021163424074567274,0.0026938624476589737,0.0015924562204623768,0.0022557630591044,0.0022907212481017244,0.0017489090619561632,63,77
rs1554668813,VCP,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6,single nucleotide variant,missense variant,9,35065355,"M158V, M113V",Pathogenic,A,G,rs1554668813,35065355.0,VCP,9,0.001031321945107831,0.0016493539838228356,0.0010755887957856754,0.0006437750440753045,0.0009192882045805417,0.0008686036972747979,30,32
rs1554668814,VCP,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6,single nucleotide variant,missense variant,9,35065358,"G112R, G157R",Pathogenic,G,A,rs1554668814,35065358.0,VCP,9,0.0015913968176483634,0.001950299062567406,0.0014117904927401414,0.0012677692280549779,0.001396888489481827,0.0019302368153974647,47,41
rs121909330,VCP,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6,single nucleotide variant,missense variant,9,35065364,"R155S, R110S",Pathogenic,C,A,rs121909330,35065364.0,VCP,9,0.001582640165913802,0.0018591841292706715,0.0013801283012073039,0.0018423679578843495,0.0016971719997640607,0.0011343484414426247,47,50
rs2490370338,VCP,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6,single nucleotide variant,missense variant,9,35066738,"G83S, G128S",Likely pathogenic,G,A,rs2490370338,35066738.0,VCP,9,0.004261006258108076,0.005050091879112376,0.004001657767924502,0.002308249809677061,0.004465650306566262,0.0054793815272601775,127,128
rs1828864269,VCP,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1,single nucleotide variant,missense variant,9,35067899,"D53E, D98E",Likely pathogenic,T,A,rs1828864269,35067899.0,VCP,9,0.0019148535759050457,0.0019535032386439597,0.001919463223803504,0.0019820863034869423,0.0019584718452243643,0.001760743268366457,57,56
rs864309502,VCP,Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,single nucleotide variant,missense variant,9,35067903,"G97E, G52E",Pathogenic,G,A,rs864309502,35067903.0,VCP,9,0.0017525943237432459,0.002415223924625054,0.0013688988354890073,0.0015501994783873887,0.0017842802673265004,0.001644369112888279,52,49
rs758169026,VCP,Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,single nucleotide variant,missense variant,9,35067909,"R50H, R95H",Likely pathogenic,G,A,rs758169026,35067909.0,VCP,9,0.0009279478029589814,0.0008358220879437379,0.0008796950542760757,0.0009115174494862603,0.0012117759699250203,0.0008009284531638128,27,33
rs121909332,VCP,Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,single nucleotide variant,missense variant,9,35067910,"R50S, R95S",Likely pathogenic,C,A,rs121909332,35067910.0,VCP,9,0.0021138803125974374,0.002097695191085454,0.0026144849077472227,0.0014798462151839559,0.002364454505040975,0.0020129207439295816,63,59
rs121909332,VCP,Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,single nucleotide variant,missense variant,9,35067910,"R95G, R50G",Pathogenic,C,G,rs121909332,35067910.0,VCP,9,0.0018992786244315634,0.0021022125224129445,0.0023998310114171097,0.001079088076289246,0.001667202874520668,0.002248058637517849,56,52
rs1563980966,VCP,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6,single nucleotide variant,missense variant,9,35067920,"N46K, N91K",Likely pathogenic,C,A,rs1563980966,35067920.0,VCP,9,0.0022113665125891276,0.0024477526614730244,0.0027235883075972943,0.0012833254861690545,0.0017301476582876143,0.00287201844941865,66,54
rs1563980966,VCP,Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,single nucleotide variant,missense variant,9,35067920,"N46K, N91K",Likely pathogenic,C,G,rs1563980966,35067920.0,VCP,9,0.0010316644748925817,0.0013433166152238118,0.0010437560058502169,0.0006086803470318899,0.001426745935433278,0.0007358234709237122,30,27
rs863225291,VCP,Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,single nucleotide variant,missense variant,9,35067922,"N91Y, N46Y",Pathogenic,A,T,rs863225291,35067922.0,VCP,9,0.0010079427544820011,0.001589894623968916,0.0012069458042090577,0.000792364854859734,0.0007448747068800076,0.0007056337824922916,30,41
rs900105227,VCP,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6,single nucleotide variant,missense variant,9,35067927,"R44Q, R89Q",Pathogenic,G,A,rs900105227,35067927.0,VCP,9,0.002682606511770392,0.002913335861814095,0.0031000136897680317,0.0020086390542612123,0.0026073480202196617,0.0027836959327889594,80,68
rs2118840030,SPTLC1,Amyotrophic lateral sclerosis,Deletion,inframe_deletion|5 prime UTR variant,9,92112497 - 92112502,,Likely pathogenic,N,-,rs2118840030,92112497.0,SPTLC1,9,0.001738990560915836,0.0015081814952785822,0.002261915463814566,0.0018404026258639107,0.0019841620318816564,0.0011002911877404644,52,55
9:132271758,SETX,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4",Deletion,frameshift variant,9,132271758,C2384fs,Pathogenic,N,-,9:132271758,132271758.0,SETX,9,0.0007293136607109029,0.0006429090627971336,0.0008492813912826371,0.0008111178010106454,0.0004806099012778954,0.0008626501471862024,21,20
rs1554804809,SETX,"Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",single nucleotide variant,splice donor variant,9,132275254,,Likely pathogenic,T,C,rs1554804809,132275254.0,SETX,9,0.001551854902505778,0.0017414381185765742,0.0015505790496973218,0.0008965992227739323,0.0019844954186469042,0.0015861627028341575,46,44
rs1186690391,SETX,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4",Deletion,splice acceptor variant,9,132277153 - 132277155,,Likely pathogenic,N,-,rs1186690391,132277153.0,SETX,9,0.0014819529483324919,0.001784202818754631,0.0014371161710934595,0.0010406972761161923,0.0014609741141938678,0.0016867743615043087,44,41
rs1038776365,SETX,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4",single nucleotide variant,splice donor variant,9,132278069,,Likely pathogenic,G,T,rs1038776365,132278069.0,SETX,9,0.0009806985203380469,0.001542997791183738,0.0009567896574857815,0.0007187987693294141,0.000841668569448879,0.0008432378142424207,29,26
9:132283388 - 132283389,SETX,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",Duplication,frameshift variant,9,132283388 - 132283389,Q2141fs,Pathogenic,N,NN,9:132283388 - 132283389,132283388.0,SETX,9,0.0007835048800218971,0.0008378916192231374,0.0008549971651513653,0.0007588060576055561,0.000582641478870918,0.0008831880792585092,23,25
rs2538904662,SETX,Inborn genetic diseases,Microsatellite,frameshift variant,9,132283388 - 132283389,Q2141fs,Pathogenic,N,-,rs2538904662,132283388.0,SETX,9,0.00029206714913567513,0.00032127011609986965,0.00030538259474667003,0.00035327979763822984,0.0002522204382021145,0.0002281827989914916,8,15
rs1844047388,SETX,"Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",single nucleotide variant,nonsense,9,132288292,Q2090*,Pathogenic,C,T,rs1844047388,132288292.0,SETX,9,0.0009688756928672422,0.0006905373476493041,0.0013930924321845996,0.0006613624102690455,0.0010204151838566684,0.0010789710903765935,29,34
rs754618817,SETX,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4",Duplication,splice donor variant,9,132288547 - 132288548,,Likely pathogenic,N,NN,rs754618817,132288547.0,SETX,9,0.0008683922678328776,0.0009923159137924145,0.0010771057990747737,0.0003756160190535675,0.0010683530300071192,0.0008285705772365124,26,24
9:132296894,SETX,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4",single nucleotide variant,missense variant,9,132296894,L1981R,Pathogenic,T,G,9:132296894,132296894.0,SETX,9,0.0018783259459329038,0.0013681170572334396,0.0018728123513303365,0.0017369426000748652,0.002986899292828892,0.0014268584281969853,56,53
rs776632212,SETX,"Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",Deletion,frameshift variant,9,132326334,T1755fs,Pathogenic,N,-,rs776632212,132326334.0,SETX,9,0.00044983455237940245,0.0005224085199791198,0.00047336294651136973,0.0004856691997839696,0.00039430014523187046,0.0003734319503906829,13,12
rs2539088969,SETX,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4",Deletion,frameshift variant,9,132326579,V1674fs,Pathogenic,N,-,rs2539088969,132326579.0,SETX,9,0.000494749729055943,0.0004968634507269856,0.00043039869856823735,0.0006128619702037201,0.0003958600193128197,0.000537764506467952,14,8
rs757883779,SETX,"Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",Duplication,frameshift variant,9,132326707 - 132326708,I1631fs,Pathogenic,N,NN,rs757883779,132326707.0,SETX,9,0.00012637140158153887,0.00013505533800180222,0.00011572715398217418,6.775284447327211e-05,0.00018091819788341345,0.0001324034735670324,3,2
rs746973259,SETX,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4",Duplication,frameshift variant,9,132326918 - 132326919,N1560fs,Pathogenic,N,NN,rs746973259,132326918.0,SETX,9,0.0001667235360536694,0.00022448964810125541,0.0001501391002414817,9.299623345184268e-05,0.00015344149622824888,0.0002125512022455184,5,4
rs2131440608,SETX,"Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",single nucleotide variant,nonsense,9,132327917,C1227*,Pathogenic,T,A,rs2131440608,132327917.0,SETX,9,0.000685486237811606,0.0006591761932614195,0.0008620945520610565,0.0003618298256322189,0.0007663599479468817,0.0007779706701564539,20,26
rs1846980272,SETX,"Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",Deletion,frameshift variant,9,132328307 - 132328310,H1096fs,Pathogenic,N,-,rs1846980272,132328307.0,SETX,9,0.0007360795382723134,0.0008057764763878827,0.0009687118104434349,0.0006796017851282519,0.0007186191742751388,0.0005076884451268585,22,19
9:132328385 - 132328386,SETX,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4",Deletion,frameshift variant,9,132328385 - 132328386,F1071fs,Pathogenic,N,-,9:132328385 - 132328386,132328385.0,SETX,9,0.000927388135002831,0.0006256702379194226,0.0006313562338380333,0.0010015399131467954,0.0012907318554617145,0.0010876424346481892,27,37
9:132328610 - 132328611,SETX,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4",Deletion,frameshift variant,9,132328610 - 132328611,R996fs,Pathogenic,N,-,9:132328610 - 132328611,132328610.0,SETX,9,4.2172003674914426e-05,4.824317122955893e-05,4.567369169968549e-05,3.4678547062788295e-05,5.007121946829835e-05,3.219338891424104e-05,1,1
rs2131461009,SETX,"Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",single nucleotide variant,missense variant,9,132330114,L495P,Pathogenic,T,C,rs2131461009,132330114.0,SETX,9,0.0002158141363266523,0.0002948281374725004,0.00023176673255530876,0.00018729306219558882,0.00015092899918024092,0.00021425375022962245,6,8
rs2131463306,SETX,Amyotrophic lateral sclerosis type 4,single nucleotide variant,missense variant,9,132330431,L389F,Likely pathogenic,A,C,rs2131463306,132330431.0,SETX,9,0.0013753880393523128,0.0012675384054750987,0.0016473833868805962,0.0013871700069818427,0.001088176319060635,0.0014866720783633907,41,35
rs2131463325,SETX,Amyotrophic lateral sclerosis type 4,Deletion,inframe_deletion,9,132330431 - 132330433,L389del,Likely pathogenic,N,-,rs2131463325,132330431.0,SETX,9,0.0026937014358260685,0.002100438571099791,0.002337876745188221,0.0029096976717682002,0.0041887341528309766,0.0019317600382431526,80,99
rs2131463657,SETX,Amyotrophic lateral sclerosis type 4,single nucleotide variant,nonsense,9,132330488,W370*,Likely pathogenic,G,A,rs2131463657,132330488.0,SETX,9,0.0006015964081405327,0.0005725392645916559,0.0005615018378820259,0.0006020497797108913,0.0005729857814014821,0.0006989053771166084,18,20
rs2539140886,SETX,Amyotrophic lateral sclerosis type 4,single nucleotide variant,splice acceptor variant,9,132331141,,Likely pathogenic,A,G,rs2539140886,132331141.0,SETX,9,0.0005573712445465117,0.0006200439568879798,0.0005817944244285368,0.0006594138836076096,0.0002814945591823339,0.0006441093986260982,16,12
rs2539238128,SETX,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4",Deletion,splice donor variant,9,132346259 - 132346262,,Pathogenic,N,-,rs2539238128,132346259.0,SETX,9,0.0002245752630818156,0.00032661474254532593,0.0001707077398964101,0.0002127941975088948,0.0001907210805941393,0.00022203855486430804,6,2
rs587776537,SETX,Inborn genetic diseases,Microsatellite,inframe_deletion,9,132346304 - 132346306,L115del,Likely pathogenic,N,-,rs587776537,132346304.0,SETX,9,0.001185460568233437,0.0013455801834449516,0.0014937208838932924,0.0006441823615736693,0.0008875779668043764,0.001556241445450895,35,39
10:13109103 - 13136886,LOC130003372|OPTN|LOC108903148|LOC108903149,"Glaucoma 1, open angle, E|Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12",Deletion,,10,13109103 - 13136886,,Pathogenic,N,-,10:13109103 - 13136886,13109103.0,LOC130003372,10,0.0017356465637773234,0.0017053998632425248,0.0021841761390872364,0.0013640780086292235,0.0022898469025207334,0.001134731905406899,51,54
10:13109123 - 13183100,LOC108903148|LOC108903149|LOC121366042|LOC130003372|LOC130003373|MCM10|OPTN,"Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, E",Deletion,,10,13109123 - 13183100,,Pathogenic,N,-,10:13109123 - 13183100,13109123.0,LOC108903148,10,0.0008369148481463693,0.0006690311132804386,0.0008222883513550109,0.0004780364882341781,0.0010678837822822487,0.0011473345055799703,25,26
10:13109279,LOC108903148|OPTN,"Amyotrophic lateral sclerosis type 12|Primary open angle glaucoma|Glaucoma 1, open angle, E",single nucleotide variant,nonsense,10,13109279,Q53*,Pathogenic,C,T,10:13109279,13109279.0,LOC108903148,10,0.0005036618887485671,0.0005895119747849192,0.000371700478421791,0.0003785492824786896,0.0005334632447327293,0.0006450844633247064,15,16
rs1564354968,LOC108903148|OPTN,"Primary open angle glaucoma|Glaucoma 1, open angle, E|Amyotrophic lateral sclerosis type 12",Duplication,frameshift variant,10,13109279 - 13109280,K55fs,Pathogenic,N,NN,rs1564354968,13109279.0,LOC108903148,10,0.00021982090945410213,0.0002603090967474748,0.00018452433182340004,0.00022768166292272025,0.000253652711746651,0.0001729367440302645,6,8
rs1359892832,LOC108903148|OPTN,"Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, E|Primary open angle glaucoma",single nucleotide variant,nonsense,10,13110348,E81*,Pathogenic,G,T,rs1359892832,13110348.0,LOC108903148,10,0.0003337532629987966,0.00027140915414526867,0.0003251788880317367,0.00024319509256878657,0.0005215097619748064,0.00030747341827338457,10,11
10:13110436 - 13110437,LOC108903148|OPTN,Amyotrophic lateral sclerosis type 12,Duplication,frameshift variant,10,13110436 - 13110437,G112fs,Pathogenic,N,NN,10:13110436 - 13110437,13110436.0,LOC108903148,10,0.0005519531121064443,0.0005608726164642288,0.00047093863507798945,0.0007221129962576903,0.0004799474438248427,0.0005258938689074708,16,20
rs113349726,LOC108903148|OPTN,"Amyotrophic lateral sclerosis type 12|Primary open angle glaucoma|Glaucoma 1, open angle, E",single nucleotide variant,splice donor variant,10,13110478,,Likely pathogenic,T,C,rs113349726,13110478.0,LOC108903148,10,0.00037906507639838137,0.0004176744821944958,0.0004355046140925769,0.00037784942324484643,0.00037103021697063086,0.00029326664548935704,11,20
rs2131488754,OPTN,"Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, E|Primary open angle glaucoma",single nucleotide variant,splice acceptor variant,10,13112452,,Likely pathogenic,G,A,rs2131488754,13112452.0,OPTN,10,0.0011208287706865373,0.0013469529791670233,0.0010351089106982834,0.0013265638640880349,0.0009676676633328816,0.0009278504361464623,33,33
rs140599944,OPTN,"Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, E|Primary open angle glaucoma",single nucleotide variant,nonsense,10,13112486,E135*,Pathogenic,G,T,rs140599944,13112486.0,OPTN,10,0.0002527027786417187,0.00036846111289481366,0.00022747373030730317,0.0001860044199753809,0.00021638623575846518,0.0002651883942726307,7,9
rs2539041527,OPTN,"Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, E",Insertion,frameshift variant,10,13112502 - 13112503,K140fs,Pathogenic,-,TC,rs2539041527,13112502.0,OPTN,10,0.000724176766145396,0.0007555382288951977,0.0006106659001070411,0.0005268476041281559,0.0010044097431756208,0.0007234223544209643,21,25
rs2131488944,OPTN,Amyotrophic lateral sclerosis type 12,single nucleotide variant,nonsense,10,13112519,Q146*,Likely pathogenic,C,T,rs2131488944,13112519.0,OPTN,10,0.00016193234232088813,0.0002003811376329399,0.0001851155532615504,0.00015207219450333952,0.00010208161172188106,0.0001700112144847297,4,8
rs1283443715,OPTN,"Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, E",Duplication,frameshift variant,10,13112532 - 13112533,Q151fs,Pathogenic,N,NN,rs1283443715,13112532.0,OPTN,10,0.00028363169986676167,0.000251090063967921,0.00024335682273690515,0.0003348411972747423,0.00039185387109865177,0.0001970165442555883,8,13
rs771268520,OPTN,"Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, E|Primary open angle glaucoma",Deletion,frameshift variant,10,13112606,E175fs,Pathogenic,N,-,rs771268520,13112606.0,OPTN,10,0.00041903182034224633,0.0003663598353600236,0.00035898162755208194,0.0005363638338283918,0.0005781371636874322,0.00025531664128330213,12,18
rs1328890259,OPTN,"Amyotrophic lateral sclerosis type 12|Primary open angle glaucoma|Glaucoma 1, open angle, E",single nucleotide variant,nonsense,10,13118910,R217*,Pathogenic,A,T,rs1328890259,13118910.0,OPTN,10,0.000791034530012381,0.0011033618348330189,0.0009534108120649511,0.0006423049086964578,0.000582283392121248,0.0006738117023462288,23,24
rs2539056279,OPTN,"Amyotrophic lateral sclerosis type 12|Primary open angle glaucoma|Glaucoma 1, open angle, E",Deletion,frameshift variant,10,13118926,K223fs,Pathogenic,N,-,rs2539056279,13118926.0,OPTN,10,0.0005578929223870099,0.0005952767915910321,0.0006850344280526904,0.00043742741132678676,0.0004024136640308717,0.0006693123169336685,16,18
rs757559365,OPTN,"Glaucoma 1, open angle, E|Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12",Microsatellite,,10,13122383 - 13122384,,Pathogenic,,,rs757559365,13122383.0,OPTN,10,0.0014407383693139672,0.0019092360366423035,0.0014927456379157788,0.0015539444471035506,0.0013093201772703905,0.0009384455476378123,43,42
rs759311192,OPTN,"Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, E|Primary open angle glaucoma",single nucleotide variant,splice acceptor variant,10,13122384,,Likely pathogenic,G,C,rs759311192,13122384.0,OPTN,10,0.0013290993959578256,0.0013609089516004513,0.0009372584903224508,0.0014646307425643693,0.0013415803802814634,0.0015411184150203932,39,42
rs1833371664,OPTN,Amyotrophic lateral sclerosis type 12,Duplication,frameshift variant,10,13122477 - 13122478,E293fs,Likely pathogenic,N,NN,rs1833371664,13122477.0,OPTN,10,0.00013611894477708676,0.0001433644517133716,0.0001996762123036898,8.874350804757803e-05,0.00012111870717831537,0.000127691844642479,4,7
rs2539062305,OPTN,"Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, E|Primary open angle glaucoma",Microsatellite,splice donor variant,10,13122487 - 13122488,,Likely pathogenic,N,-,rs2539062305,13122487.0,OPTN,10,0.0011040979095635873,0.000832798613474832,0.0012161041501598335,0.0014076708263602387,0.0008516105409212943,0.0012123054169017383,33,30
10:13124028 - 13124038,OPTN,Amyotrophic lateral sclerosis type 12,Deletion,frameshift variant,10,13124028 - 13124038,,Likely pathogenic,N,-,10:13124028 - 13124038,13124028.0,OPTN,10,0.0013024260614137018,0.0016107837110209328,0.0015805769868964825,0.0008541810608643756,0.0009920833587666576,0.0014745051895200608,39,41
rs778911925,OPTN,"Primary open angle glaucoma|Glaucoma 1, open angle, E|Amyotrophic lateral sclerosis type 12",Deletion,frameshift variant,10,13124098 - 13124102,R329fs,Pathogenic,N,-,rs778911925,13124098.0,OPTN,10,0.00035241030379851943,0.00046662620632310193,0.000521588146829196,0.00025265293973130565,0.0002704250002722903,0.0002507592258367032,10,13
rs746420444,OPTN,Inborn genetic diseases,single nucleotide variant,nonsense,10,13125422,Q335*,Pathogenic,C,T,rs746420444,13125422.0,OPTN,10,0.0005623820725329101,0.0004897216942568904,0.0004027069285394385,0.0006932836761776026,0.00047541201515582986,0.0007507860485347887,16,27
rs1564365123,OPTN,"Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, E",Deletion,frameshift variant,10,13125522,M368fs,Pathogenic,N,-,rs1564365123,13125522.0,OPTN,10,5.133984358503611e-05,6.033728835019966e-05,4.664038749706741e-05,5.292345132786932e-05,4.593385581582644e-05,5.086423493421767e-05,1,1
rs1833451208,OPTN,Amyotrophic lateral sclerosis type 12,Deletion,frameshift variant,10,13126014,T406fs,Pathogenic,N,-,rs1833451208,13126014.0,OPTN,10,0.0009115995080073872,0.001047757623704005,0.0009064868712349576,0.0008341369628881242,0.0011030864312630625,0.000666529650946786,27,24
10:13126037,OPTN,"Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, E",single nucleotide variant,nonsense,10,13126037,E414*,Pathogenic,G,T,10:13126037,13126037.0,OPTN,10,0.00014895522786639327,0.0001963080171416333,0.0001499671430636476,8.474971763192498e-05,9.342255926140074e-05,0.0002203287022333598,4,5
10:13127785,OPTN,"Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, E",Deletion,frameshift variant,10,13127785,K429fs,Pathogenic,N,-,10:13127785,13127785.0,OPTN,10,0.00010958850409465645,0.00011923853040719962,0.00012342809230238793,8.379135055822161e-05,8.131100950028898e-05,0.00014017353770518412,3,2
rs1206423781,OPTN,"Glaucoma 1, open angle, E|Amyotrophic lateral sclerosis type 12|Primary open angle glaucoma",Deletion,frameshift variant,10,13127791 - 13127792,L430fs,Pathogenic,N,-,rs1206423781,13127791.0,OPTN,10,0.0009763075756324569,0.0010679945047904426,0.0007825690162947082,0.001020779492636136,0.0009230760133058877,0.0010871188511351096,29,22
rs2539070896,OPTN,"Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, E|Primary open angle glaucoma",Duplication,frameshift variant,10,13127819 - 13127820,D445fs,Pathogenic,N,NN,rs2539070896,13127819.0,OPTN,10,0.0008638023520259695,0.0007227025936862415,0.0006797254932587346,0.0010682351772791547,0.0012547347192084057,0.0005936137766973105,25,34
rs2131520977,OPTN,Amyotrophic lateral sclerosis type 12,single nucleotide variant,missense variant,10,13127902,Q467P,Likely pathogenic,A,C,rs2131520977,13127902.0,OPTN,10,0.0021397566326237455,0.0033841467751139207,0.0016791033786427592,0.001297299187155407,0.002380736009825941,0.0019574978123807017,64,56
rs1370982012,OPTN,"Primary open angle glaucoma|Glaucoma 1, open angle, E|Amyotrophic lateral sclerosis type 12",single nucleotide variant,splice donor variant,10,13127904,,Likely pathogenic,G,A,rs1370982012,13127904.0,OPTN,10,0.00033556172297456244,0.0004820099642109439,0.0003718180517922137,0.00022197280772379887,0.0002560968861276078,0.0003459109050182479,10,7
rs267606929,OPTN,Amyotrophic lateral sclerosis type 12,single nucleotide variant,missense variant,10,13132098,E478G,Pathogenic,A,G,rs267606929,13132098.0,OPTN,10,0.0028308890488310478,0.0035969233898343546,0.00277688414322423,0.0020320673522561195,0.0031897030278645404,0.0025588673309759934,84,98
rs780777015,OPTN,"Primary open angle glaucoma|Glaucoma 1, open angle, E|Amyotrophic lateral sclerosis type 12",single nucleotide variant,nonsense,10,13133521,Q518*,Pathogenic,C,T,rs780777015,13133521.0,OPTN,10,0.0006582795026194611,0.001000672678840665,0.0006764692436791622,0.0005774846352569013,0.0004947166667250834,0.0005420542885954939,19,22
rs1357375850,OPTN,"Glaucoma 1, open angle, E|Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12",single nucleotide variant,missense variant,10,13136802,K557T,Likely pathogenic,A,C,rs1357375850,13136802.0,OPTN,10,0.0016819701697438857,0.002011246651976512,0.001736178397683713,0.0010239931938868716,0.0022868976254170523,0.0013515349797552805,50,45
10:80166889,ANXA11,Amyotrophic lateral sclerosis type 23,single nucleotide variant,splice donor variant,10,80166889,,Pathogenic,G,A,10:80166889,80166889.0,ANXA11,10,0.0009228027364513794,0.000914790860180439,0.0010628163101083713,0.0008776691243382639,0.0009365491728518639,0.0008221882147779588,27,25
rs1844420892,ERLIN1,Juvenile amyotrophic lateral sclerosis,single nucleotide variant,missense variant|non-coding transcript variant|intron variant,10,100178156,"V10A, V94A",Pathogenic,T,C,rs1844420892,100178156.0,ERLIN1,10,0.0018859957652885618,0.001984994639353773,0.0028033387793440813,0.0014578726089239926,0.0013692592066453307,0.0018145135921756317,56,43
rs781660354,PRPH|TROAP-AS1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,non-coding transcript variant|splice acceptor variant,12,49296431,,Likely pathogenic,G,A,rs781660354,49296431.0,PRPH,12,0.0009763552971915083,0.0010177153886369787,0.0013907032281895253,0.0007930881905226122,0.00085986237729754,0.0008204073013108853,29,19
12:49297147,LOC124629354|PRPH|TROAP-AS1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,non-coding transcript variant|splice acceptor variant,12,49297147,,Likely pathogenic,G,A,12:49297147,49297147.0,LOC124629354,12,0.00048361395094602237,0.0006202126416001507,0.00044946769636802845,0.0003783362803946119,0.0004710550401480975,0.0004989980962192234,14,11
rs2498984328,LOC124629354|PRPH|TROAP-AS1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,non-coding transcript variant|nonsense,12,49297196,Q307*,Likely pathogenic,C,T,rs2498984328,49297196.0,LOC124629354,12,0.00011847708828810824,0.00010582726706988367,0.00014188577624379856,0.0001123778190063169,0.00014299581703508196,8.929876208546011e-05,3,2
rs1592173638,HNRNPA1,Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3,single nucleotide variant,missense variant|non-coding transcript variant,12,54283922,"P288A, P340A",Likely pathogenic,C,G,rs1592173638,54283922.0,HNRNPA1,12,0.0008122691416122651,0.0011946211504266205,0.0006307887623370604,0.0006048989240702812,0.0008185476014819396,0.0008124892697454244,24,26
12:57572640,KIF5A,Spastic paraplegia,single nucleotide variant,nonsense,12,57572640,"R455*, R544*",Pathogenic,C,T,12:57572640,57572640.0,KIF5A,12,0.0008738354001328636,0.0010980792914021607,0.0007616560276169788,0.0010358326939102918,0.0005380879534453208,0.0009355210342895656,26,21
rs1402429085,KIF5A,Spastic paraplegia,single nucleotide variant,intron variant,12,57582599,,Pathogenic,C,T,rs1402429085,57582599.0,KIF5A,12,0.0013374134858412132,0.0013782555197306755,0.001197014981333706,0.0012360544710416476,0.0013880407062158012,0.0014877017508842362,40,43
rs1555179091,KIF5A,Spastic paraplegia,single nucleotide variant,splice donor variant,12,57582630,,Likely pathogenic,G,T,rs1555179091,57582630.0,KIF5A,12,0.001095379865674094,0.0011323296187118216,0.0010311216894062605,0.0007434856153830181,0.0013101372798790833,0.0012598251249902861,32,26
rs1555201919,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,nonsense,12,64455874,Q2*,Pathogenic,C,T,rs1555201919,64455874.0,TBK1,12,0.00018590441717390092,0.00019158136822319905,0.00020188815412022743,0.0002029576642233424,0.00015559370485250924,0.0001775011944502265,5,9
rs2539476696,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Indel,frameshift variant,12,64455938 - 64455940,V23fs,Likely pathogenic,N,-,rs2539476696,64455938.0,TBK1,12,0.0004899459003673988,0.0005597856176613201,0.0004063463527960254,0.00047153717074575576,0.00042655097650537454,0.0005855093841285178,14,11
rs1279619378,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Duplication,frameshift variant,12,64455939 - 64455940,R25fs,Pathogenic,N,NN,rs1279619378,64455939.0,TBK1,12,6.674343695944817e-05,6.614604695018017e-05,9.091832579570685e-05,4.008295944670184e-05,9.060615884329627e-05,4.596369376135571e-05,2,1
rs1592350883,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Duplication,frameshift variant,12,64455954 - 64455955,K30fs,Pathogenic,N,NN,rs1592350883,64455954.0,TBK1,12,0.0003225727711643372,0.0002682120421030117,0.0003801601333895343,0.00022132199549800745,0.0002899760811742857,0.00045319360365684685,9,8
rs1592350887,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,synonymous variant,12,64455957,,Pathogenic,G,A,rs1592350887,64455957.0,TBK1,12,0.0008358592423429675,0.0006570486923214955,0.0011034897631197048,0.0011694442715520681,0.0006005198738131091,0.0006487936109084596,25,27
rs2539482429,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,nonsense,12,64460202,L34*,Pathogenic,T,G,rs2539482429,64460202.0,TBK1,12,0.0006964354106641678,0.0009458478801861809,0.00043007668513368063,0.0007257480823394916,0.0008321826796824273,0.0005483217259790589,20,29
12:64460284 - 64460287,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,frameshift variant,12,64460284 - 64460287,L62fs,Pathogenic,N,-,12:64460284 - 64460287,64460284.0,TBK1,12,0.00015108496309298888,0.00015550374853172128,0.0001688382915856727,0.00015503242380299976,8.194431724599602e-05,0.00019410603429855463,4,6
12:64460307 - 64460310,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,frameshift variant,12,64460307 - 64460310,K69fs,Likely pathogenic,N,-,12:64460307 - 64460310,64460307.0,TBK1,12,0.0013155621116249575,0.0016534103715392494,0.0009926923997020493,0.0013194831756718794,0.0007463824699738085,0.001865842141237801,39,44
12:64464386,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,missense variant,12,64464386,L94S,Likely pathogenic,T,C,12:64464386,64464386.0,TBK1,12,0.0007687853723182202,0.0008173244687313309,0.0008211499738793681,0.0008044944117766547,0.0006979092551321404,0.0007030487520716071,23,28
rs2539489004,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,frameshift variant,12,64464405 - 64464414,S102fs,Pathogenic,N,-,rs2539489004,64464405.0,TBK1,12,0.0007051023084212774,0.0008341505664483569,0.0007677929692046788,0.0006447004853764655,0.0007994032501375564,0.0004794642709393297,21,24
rs200879808,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,missense variant,12,64464457,D118N,Likely pathogenic,G,A,rs200879808,64464457.0,TBK1,12,0.003941690601565535,0.00402239503176348,0.0038509429863756908,0.0033872390273742125,0.005181582190347969,0.0032662937719663203,117,108
rs1565814492,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Duplication,frameshift variant,12,64466962 - 64466963,I141fs,Pathogenic,N,NN,rs1565814492,64466962.0,TBK1,12,0.000356518638011242,0.00036904587174777507,0.0003821284708844038,0.00031070341499115365,0.0004630116567048479,0.0002577037757280296,10,9
rs1565814529,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Microsatellite,frameshift variant,12,64466995 - 64466996,Y153fs,Pathogenic,N,-,rs1565814529,64466995.0,TBK1,12,0.00023093899879273903,0.00027003733077688385,0.0002073464063998635,0.00026934025279209083,0.0001866578581819964,0.0002213131458128605,6,6
rs2539493394,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,frameshift variant,12,64467061,Y174fs,Pathogenic,N,-,rs2539493394,64467061.0,TBK1,12,0.0006947644406577063,0.0011008188100817217,0.0007511078476795121,0.000424839531499808,0.00042882759701489066,0.0007682284170125993,20,14
rs2539503647,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,splice donor variant,12,64474392,,Pathogenic,T,G,rs2539503647,64474392.0,TBK1,12,9.764663063957049e-05,8.554230755254893e-05,0.00010327968274951693,9.849908598401943e-05,0.00012412010407926175,7.679197283250542e-05,2,7
rs2539510971,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,frameshift variant,12,64480030,K241fs,Pathogenic,N,-,rs2539510971,64480030.0,TBK1,12,0.000946631567190336,0.0009159908536507131,0.0008027673797426286,0.0007502128322426575,0.0010967842952009069,0.0011674024751147738,28,27
rs2539511024,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Microsatellite,frameshift variant,12,64480046 - 64480047,S247fs,Pathogenic,N,-,rs2539511024,64480046.0,TBK1,12,0.0008915558957029908,0.0009362860984360429,0.0010066707732811367,0.0008441572104870265,0.0010406170459893423,0.000630048350321405,26,21
rs2539511036,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,nonsense,12,64480058,Q250*,Pathogenic,C,T,rs2539511036,64480058.0,TBK1,12,0.00038120913333448584,0.0003050205639005018,0.0003847792419660541,0.00038809367442032205,0.000318752061521611,0.0005094001248639403,11,7
12:64481918,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,nonsense,12,64481918,Q297*,Pathogenic,C,T,12:64481918,64481918.0,TBK1,12,0.00022153167823514246,0.0002945761974578174,0.00020735716565177916,0.00020746542906619614,0.00016388955697930083,0.0002343700420206187,6,9
12:64481963 - 64481964,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Duplication,frameshift variant,12,64481963 - 64481964,H312fs,Pathogenic,N,NN,12:64481963 - 64481964,64481963.0,TBK1,12,0.0010799737422243776,0.0009997344280183547,0.0012417984603127275,0.0009280024284910424,0.001096731979400481,0.0011336014148992824,32,39
rs369620088,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,nonsense,12,64481973,S315*,Pathogenic,C,A,rs369620088,64481973.0,TBK1,12,0.0004639343223933579,0.00046854284723655854,0.0005953067696820265,0.000407815191561894,0.00031179203861361667,0.0005362147648726935,13,25
rs758357594,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,missense variant,12,64484380,R357Q,Pathogenic,G,A,rs758357594,64484380.0,TBK1,12,0.0015278777970840086,0.0016264577119588142,0.0013059943990522329,0.001508608858161373,0.0016817509973787942,0.0015165770188688293,45,48
rs2136078402,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,splice donor variant,12,64484500,,Likely pathogenic,G,T,rs2136078402,64484500.0,TBK1,12,0.0004822690850302664,0.0006740372900771052,0.0003980998274200551,0.00031797889897419864,0.0006067143401960004,0.0004145150684839726,14,19
rs2136078402,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,splice donor variant,12,64484500,,Likely pathogenic,G,A,rs2136078402,64484500.0,TBK1,12,0.0006738619485304523,0.0007147539716887576,0.0008952783120271284,0.0006054947682607555,0.0006615159986294525,0.0004922666920461677,20,30
rs2539519111,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,frameshift variant,12,64485499,A412fs,Pathogenic,N,-,rs2539519111,64485499.0,TBK1,12,0.0009117009430457091,0.001232335153421367,0.0009958529352009427,0.0009293492105504551,0.000754162822503546,0.0006468045935522341,27,33
rs2040816609,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,nonsense,12,64485949,,Pathogenic,N,-,rs2040816609,64485949.0,TBK1,12,8.570739623919145e-05,0.00012157378625265948,0.00010496680627555459,8.367833299416057e-05,6.35395099299522e-05,5.477854574363042e-05,2,2
rs2539520026,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,nonsense,12,64485982,Y435*,Pathogenic,T,A,rs2539520026,64485982.0,TBK1,12,0.0002612540723728133,0.0001975758383957748,0.00022696114357439014,0.00032702292737997414,0.00033604982036853005,0.0002186606321453974,7,11
rs769588220,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,nonsense,12,64485995,"R440X, R440*",Pathogenic,C,T,rs769588220,64485995.0,TBK1,12,0.0006578120279379627,0.0006443987507620142,0.0006411204048984641,0.0006793312508920798,0.0007379187346133832,0.0005862909985238721,19,23
rs767898276,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,splice donor variant,12,64486018,,Pathogenic,G,A,rs767898276,64486018.0,TBK1,12,0.00026160520896169163,0.00024283772172220512,0.0001793797437620056,0.0002840414472806063,0.000304229298344651,0.0002975378336989902,7,8
rs1461457058,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,splice acceptor variant,12,64488486,,Likely pathogenic,G,C,rs1461457058,64488486.0,TBK1,12,0.0014581473004911774,0.001882904124145664,0.0013923489112317373,0.0014540011669509098,0.001522964488245447,0.0010385178118821285,43,44
rs2539523784,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,frameshift variant,12,64488517 - 64488518,V458fs,Pathogenic,N,-,rs2539523784,64488517.0,TBK1,12,0.0006987355667337055,0.0004747339830841411,0.000818885989219111,0.0005379207327384823,0.0008963262250592061,0.0007658109035675868,20,26
rs1178717934,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Duplication,frameshift variant,12,64488523 - 64488524,T462fs,Pathogenic,N,NN,rs1178717934,64488523.0,TBK1,12,0.0008849467571653364,0.0012983214389636704,0.000672724103032404,0.0006368205954705599,0.0008279337993649377,0.0009889338489951099,26,18
rs1476919390,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,frameshift variant,12,64488528 - 64488531,T462fs,Pathogenic,N,-,rs1476919390,64488528.0,TBK1,12,0.0004647538126067467,0.0005748270299429485,0.0004837887839775973,0.000618403324860735,0.0003779667102948036,0.0002687832139576494,13,9
rs1555204731,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,frameshift variant,12,64488532 - 64488533,E463fs,Pathogenic,N,-,rs1555204731,64488532.0,TBK1,12,0.0005545896064176466,0.0005534004112558928,0.0004157233906147441,0.0006184298037360998,0.0007741137893269881,0.0004112806371545083,16,24
rs876657405,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Microsatellite,frameshift variant,12,64488580 - 64488581,V479fs,Likely pathogenic,N,-,rs876657405,64488580.0,TBK1,12,0.0009354248518657728,0.000740039527004239,0.0008026348413671157,0.0008967825781478347,0.0011628505447810703,0.0010748167680286046,28,20
rs2539525878,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,splice acceptor variant,12,64490040,,Likely pathogenic,G,T,rs2539525878,64490040.0,TBK1,12,0.001066981429158889,0.001323091891399318,0.0009869402673219761,0.0013951132138416379,0.0007528973036083216,0.0008768644696231918,31,21
rs1280163869,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,nonsense,12,64490094,S499*,Pathogenic,C,G,rs1280163869,64490094.0,TBK1,12,0.0006513912390007298,0.0009141874241311701,0.00055181885753804,0.0006173571425392798,0.0005556582667148444,0.0006179345040803146,19,21
rs2539534664,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,frameshift variant,12,64495596 - 64495599,D546fs,Pathogenic,N,-,rs2539534664,64495596.0,TBK1,12,0.0002588058345266406,0.00021380802194768408,0.0002777724029049479,0.00023528853060807758,0.0002589507794085074,0.0003082094377639861,7,8
rs2539534855,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,splice acceptor variant,12,64495697,,Likely pathogenic,A,T,rs2539534855,64495697.0,TBK1,12,0.00033366373905143197,0.00047728838462698773,0.00028881509741195214,0.00017850474048806202,0.00035265051815520926,0.0003710599545749485,10,11
12:64495748,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,nonsense,12,64495748,Q565*,Pathogenic,C,T,12:64495748,64495748.0,TBK1,12,0.00029108320292193016,0.0003427897630460586,0.00026916203550678564,0.00019530832192441732,0.00036805502872211507,0.0002801008654102743,8,10
rs2136087722,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,frameshift variant,12,64496385,E580fs,Pathogenic,N,-,rs2136087722,64496385.0,TBK1,12,0.0005814428348604918,0.0009791496618208053,0.0006098620355242693,0.00029838152045952564,0.0004468813332161857,0.0005729396232816732,17,14
12:64496407,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,splice donor variant,12,64496407,,Likely pathogenic,G,A,12:64496407,64496407.0,TBK1,12,0.0010853735391667331,0.0009933804612898094,0.0008507213384596628,0.0008720859917554435,0.0011545952183814971,0.001556084685947253,32,30
12:64496948,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,,12,64496948,,Pathogenic,N,-,12:64496948,64496948.0,TBK1,12,0.00039617246143147655,0.00033457282048752503,0.00026000989952495833,0.00030755500397763007,0.0005562927125619569,0.0005224318706053123,11,13
rs2040932099,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,frameshift variant,12,64496957 - 64496958,Y591fs,Pathogenic,N,-,rs2040932099,64496957.0,TBK1,12,0.000856071235458686,0.0008501174754946052,0.0008959537726704968,0.0005623888969109444,0.001292062509618841,0.0006798335225985417,25,31
12:64497006 - 64497007,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Microsatellite,nonsense,12,64497006 - 64497007,,Pathogenic,-,GCCGGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGTGGATCATGAGGTCAG,12:64497006 - 64497007,64497006.0,TBK1,12,0.0007316180575315268,0.0008519820440266248,0.0007005783985744216,0.0007305854702910184,0.0008661235335412848,0.0005088208412242842,21,32
rs2136088227,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,frameshift variant,12,64497032 - 64497035,S616fs,Pathogenic,N,-,rs2136088227,64497032.0,TBK1,12,0.00017946591936807547,0.0002791493284581108,0.00016786671229641163,0.00014452782681431534,0.00016114067907609613,0.00014464505019544334,5,7
rs2539537276,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,nonsense,12,64497044,W619*,Pathogenic,G,A,rs2539537276,64497044.0,TBK1,12,0.0006303637630564593,0.0007944272376348914,0.0007675020224883413,0.0005902285827149596,0.0006563786607673734,0.00034328231167673063,18,29
rs2539537429,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,splice acceptor variant,12,64497162,,Likely pathogenic,G,A,rs2539537429,64497162.0,TBK1,12,0.0007289607863997978,0.0006354360699992234,0.001155143758185559,0.0007032417880280721,0.0006293046359708412,0.0005216776798152927,21,30
rs2539537514,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,frameshift variant,12,64497217,D639fs,Pathogenic,N,-,rs2539537514,64497217.0,TBK1,12,0.0009752262917496525,0.0010669211035720686,0.0010272708506750628,0.0007298664539820872,0.0011127358379481758,0.0009393372125708669,29,36
rs2136088420,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,nonsense,12,64497234,S645*,Pathogenic,C,G,rs2136088420,64497234.0,TBK1,12,0.0005823150592088675,0.0006172648882988113,0.0005967567352354667,0.000430706231211575,0.0007708559781002664,0.0004959914631982182,17,18
rs2539537579,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Deletion,frameshift variant,12,64497256,N652fs,Pathogenic,N,-,rs2539537579,64497256.0,TBK1,12,0.0008297363683014505,0.0010771104835342522,0.0005985154745788012,0.0006080936107497321,0.0010302661926335755,0.0008346960800108911,24,20
rs1565824978,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,splice acceptor variant,12,64497646,,Likely pathogenic,A,T,rs1565824978,64497646.0,TBK1,12,0.001195986881568762,0.0013990207790926662,0.0010235650140721251,0.0008824634746733767,0.0017726400787647805,0.0009022450612408621,35,32
rs2136088934,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,Microsatellite,frameshift variant,12,64497658 - 64497659,L658fs,Pathogenic,N,-,rs2136088934,64497658.0,TBK1,12,0.00016825726260804528,0.00019645227260084474,0.0001537926697872171,0.00018541929240193275,0.00014630134434799228,0.00015932073390223958,5,3
rs2136088954,TBK1,Frontotemporal dementia and/or amyotrophic lateral sclerosis 4,single nucleotide variant,nonsense,12,64497666,Q660*,Likely pathogenic,C,T,rs2136088954,64497666.0,TBK1,12,0.00016792115781715214,0.00023306661650110446,0.00015267084569728188,0.0001420601469924183,0.0001271362835584703,0.0001846718963364857,5,4
rs121909542,ANG|EGILA|RNASE4,Amyotrophic lateral sclerosis type 9,single nucleotide variant,non-coding transcript variant|missense variant|intron variant,14,20693719,S52N,Likely pathogenic,G,A,rs121909542,20693719.0,ANG,14,0.00443822741954935,0.0031796789094749897,0.006782784118879508,0.0029028122891331404,0.004607296342390635,0.004718565437868475,132,136
15:44563294,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,single nucleotide variant,nonsense,15,44563294,"Q2274*, Q2387*, Q2339*",Likely pathogenic,C,T,15:44563294,44563294.0,SPG11,15,0.0009231143220357629,0.0009618194186660639,0.0006982630698215879,0.0007208644567980476,0.0014921366389510297,0.0007424880259420847,27,29
15:44564602,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,single nucleotide variant,nonsense,15,44564602,"E2366*, E2253*, E2318*",Likely pathogenic,G,T,15:44564602,44564602.0,SPG11,15,0.0002530099237260572,0.0003565625809078787,0.0003531761328766902,0.00013231832284527772,0.00028880662266505034,0.00013418595933538881,7,5
15:44565994,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,single nucleotide variant,nonsense,15,44565994,"Q2287*, Q2174*, Q2239*",Pathogenic,C,T,15:44565994,44565994.0,SPG11,15,0.0005483363760023622,0.0008452680125466931,0.0006726112477155347,0.000285622839106647,0.0005683630664622763,0.00036981671418066076,16,12
15:44566277 - 44566287,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Deletion,frameshift variant,15,44566277 - 44566287,"G2145fs, G2210fs, G2258fs",Likely pathogenic,N,-,15:44566277 - 44566287,44566277.0,SPG11,15,0.000844306622965105,0.0006277215300982766,0.0007743058839577899,0.0010228624746405153,0.0008948663871796265,0.0009017768389493171,25,20
15:44567583,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Deletion,nonsense,15,44567583,,Likely pathogenic,N,-,15:44567583,44567583.0,SPG11,15,0.0008563656484279414,0.001202007385818402,0.0009360766803987457,0.0005222069670199531,0.0008196476697781811,0.0008018895391244256,25,36
15:44570524,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,single nucleotide variant,splice donor variant,15,44570524,,Likely pathogenic,G,C,15:44570524,44570524.0,SPG11,15,0.0009351991483656973,0.001259397465043905,0.000830251760996872,0.0007555808944409322,0.0008602572525093946,0.0009705083688373819,28,18
15:44572681,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,single nucleotide variant,splice donor variant,15,44572681,,Likely pathogenic,T,C,15:44572681,44572681.0,SPG11,15,0.0013320101156917505,0.0015033669178634277,0.0012380185373073874,0.0007509832673162427,0.0015115596406171988,0.0016561222153544956,39,38
15:44572773,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,single nucleotide variant,nonsense,15,44572773,"Q2037*, Q1972*, Q2085*",Likely pathogenic,C,T,15:44572773,44572773.0,SPG11,15,0.0013339080596602335,0.0011752060944072047,0.0011368268194110022,0.0016532791568565524,0.0018547017000852537,0.0008495265275411541,39,40
15:44572822,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,single nucleotide variant,splice acceptor variant,15,44572822,,Likely pathogenic,A,G,15:44572822,44572822.0,SPG11,15,0.0011075337297314432,0.0015650383340075993,0.0008661874414157384,0.0008875841550508454,0.0013832862007782023,0.0008355725174048304,33,47
15:44573558,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,single nucleotide variant,nonsense|intron variant,15,44573558,"S2065*, S2017*",Likely pathogenic,C,A,15:44573558,44573558.0,SPG11,15,0.0004071803475351553,0.0005983230594962005,0.000491866010932968,0.0002547863188631846,0.000270715688064531,0.00042021066031889214,12,10
15:44574897 - 44574901,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Deletion,splice donor variant|intron variant,15,44574897 - 44574901,,Likely pathogenic,N,-,15:44574897 - 44574901,44574897.0,SPG11,15,0.001310786374519228,0.001768496464526326,0.0014085169635021269,0.001322066934943504,0.0011035300232245513,0.0009513214863996316,39,33
15:44583974 - 44583983,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Deletion,frameshift variant,15,44583974 - 44583983,"Y1852fs, Y1900fs",Likely pathogenic,N,-,15:44583974 - 44583983,44583974.0,SPG11,15,0.0009107832862811158,0.0009071380057853738,0.001008670197653529,0.0009623610960943412,0.0006887374939102333,0.000987009637962101,27,39
15:44584003,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,single nucleotide variant,nonsense,15,44584003,"E1845*, E1893*",Likely pathogenic,G,T,15:44584003,44584003.0,SPG11,15,0.0005316928997744702,0.0007085126349086582,0.00051539080772747,0.00036085079890474283,0.0005895484110927833,0.0004841618462386965,15,17
15:44584081,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Deletion,frameshift variant,15,44584081,"E1867fs, E1819fs",Likely pathogenic,N,-,15:44584081,44584081.0,SPG11,15,0.0001896463086567936,0.00028023233176316154,0.00016438951994768834,0.0001617565750862293,0.00011428886668325884,0.00022756424980363007,5,6
15:44589289 - 44589290,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Duplication,frameshift variant,15,44589289 - 44589290,L1623fs,Likely pathogenic,N,NN,15:44589289 - 44589290,44589289.0,SPG11,15,0.0014127726680525606,0.0012651107579714266,0.0015810722181149631,0.001098234998821681,0.0015067411583596188,0.0016127042069951144,42,44
15:44589290,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Deletion,frameshift variant,15,44589290,L1623fs,Pathogenic,N,-,15:44589290,44589290.0,SPG11,15,0.0003256171519356488,0.000359205054369144,0.0004454701569799418,0.00016717328645593008,0.00044783472214124273,0.00020840253973198545,9,14
15:44589327,SPG11,Amyotrophic lateral sclerosis type 5,single nucleotide variant,nonsense,15,44589327,Q1611*,Likely pathogenic,C,T,15:44589327,44589327.0,SPG11,15,0.00043555697405682546,0.0005162723375821255,0.0004050869474903514,0.00036778612402747833,0.0005647137553528858,0.00032392570583128624,13,12
15:44595314,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Deletion,frameshift variant,15,44595314,L1527fs,Likely pathogenic,N,-,15:44595314,44595314.0,SPG11,15,0.0006499249297237077,0.0005998120901638203,0.0006160400489391342,0.0005398776154022834,0.00047860695548309224,0.0010152879386302086,19,21
rs2140971559,SPG11,Hereditary spastic paraplegia 11,single nucleotide variant,nonsense,15,44596085,Q1478*,Pathogenic,C,T,rs2140971559,44596085.0,SPG11,15,0.00048338723778398743,0.0006450744817397027,0.00035255521757194457,0.0005865074568542222,0.0004944117845511882,0.0003383872482028795,14,12
15:44596110 - 44596113,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Deletion,frameshift variant,15,44596110 - 44596113,I1469fs,Likely pathogenic,N,-,15:44596110 - 44596113,44596110.0,SPG11,15,0.00032921098989901267,0.0002490314019751714,0.0002812277263382355,0.0003033298088890421,0.00033600133314706803,0.0004764646791455464,9,13
15:44596240 - 44596241,LOC130056973|SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Deletion,frameshift variant,15,44596240 - 44596241,K1426fs,Likely pathogenic,N,-,15:44596240 - 44596241,44596240.0,LOC130056973,15,0.0008599021347473884,0.0013361658066122785,0.0006412770713416759,0.0005294440353627887,0.0009245774740882738,0.0008680462863319253,25,22
15:44596945,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,single nucleotide variant,splice acceptor variant,15,44596945,,Likely pathogenic,A,C,15:44596945,44596945.0,SPG11,15,0.0005254372698460836,0.0005283262729220006,0.0006028377037338227,0.000508410717717662,0.0004580385573666538,0.0005295730974902791,15,13
15:44598265 - 44598266,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Microsatellite,frameshift variant,15,44598265 - 44598266,R1334fs,Likely pathogenic,N,-,15:44598265 - 44598266,44598265.0,SPG11,15,0.0007496262587132794,0.0008231889589441281,0.0007427391826280586,0.0007662343459020305,0.0006040783182977333,0.0008118904877944466,22,21
15:44598363 - 44598364,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Duplication,frameshift variant,15,44598363 - 44598364,S1302fs,Likely pathogenic,N,NN,15:44598363 - 44598364,44598363.0,SPG11,15,0.000712116313370582,0.0006402574612266164,0.0006288712059424017,0.0008832492379734507,0.0006768612350041828,0.0007313424267062589,21,20
15:44598740,SPG11,Amyotrophic lateral sclerosis type 5|Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X,Deletion,frameshift variant,15,44598740,G1262fs,Likely pathogenic,N,-,15:44598740,44598740.0,SPG11,15,0.0003713215642847077,0.00043682021073359803,0.00036846395587335847,0.00017079765912754528,0.0004937868900861494,0.00038673910560288737,11,7
15:44598779 - 44598780,SPG11,Amyotrophic lateral sclerosis type 5,Insertion,frameshift variant,15,44598779 - 44598780,S1249fs,Likely pathogenic,-,CTACC,15:44598779 - 44598780,44598779.0,SPG11,15,0.0002629187789313215,0.00026969071349524043,0.00027663667514216887,0.00017028075657489033,0.0002813983402082626,0.0003165874092360456,7,7
15:44608525,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Deletion,frameshift variant,15,44608525,K1125fs,Likely pathogenic,N,-,15:44608525,44608525.0,SPG11,15,0.0001309396193325776,0.00017408713768613803,0.0001569710550762105,0.00011590947552056908,0.00011809409836855124,8.963633001141913e-05,3,5
15:44610986,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,single nucleotide variant,splice acceptor variant,15,44610986,,Likely pathogenic,G,C,15:44610986,44610986.0,SPG11,15,0.00114901596774386,0.0012003032432993765,0.0012622177241938543,0.0007662011399799292,0.0012514222623231854,0.0012649354689229552,34,33
15:44613537,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,single nucleotide variant,splice acceptor variant,15,44613537,,Likely pathogenic,G,A,15:44613537,44613537.0,SPG11,15,0.00015920561386572254,0.00017591209243209748,0.00015573102212782845,0.00016956220868143503,0.00015896855202749555,0.00013585419405975614,4,4
15:44615384 - 44615385,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Duplication,frameshift variant,15,44615384 - 44615385,Y1006fs,Likely pathogenic,N,NN,15:44615384 - 44615385,44615384.0,SPG11,15,0.00043900207351260255,0.00039240805379080055,0.000532769800140396,0.0004512847411419971,0.0004071773208888591,0.00041137045160095996,13,14
15:44615416 - 44615417,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Deletion,frameshift variant,15,44615416 - 44615417,Y995fs,Likely pathogenic,N,-,15:44615416 - 44615417,44615416.0,SPG11,15,0.0007667946977960503,0.0010976064971287695,0.000921224514002916,0.00034319568906151544,0.0007613843063526285,0.0007105624824344222,22,29
15:44615538,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,single nucleotide variant,nonsense,15,44615538,E955*,Likely pathogenic,G,T,15:44615538,44615538.0,SPG11,15,0.00024143686245178467,0.00027220028531697236,0.00027189982180621925,0.00018160707843184058,0.00020982718654112038,0.0002716499401627709,7,5
rs750101275,SPG11,Hereditary spastic paraplegia 11,Duplication,frameshift variant,15,44621766 - 44621767,S871fs,Pathogenic,N,NN,rs750101275,44621766.0,SPG11,15,0.00025860413162788075,0.000329264981050455,0.0003032810892171309,0.0002003810962097858,0.0001495072629521958,0.00031058622870983624,7,11
rs2083790483,SPG11,Amyotrophic lateral sclerosis type 5,Deletion,frameshift variant,15,44622794,F750fs,Pathogenic,N,-,rs2083790483,44622794.0,SPG11,15,0.0006375424493718664,0.0007824013220137123,0.0007091970579186798,0.0006296147024245531,0.0005890798243849683,0.0004774193401174179,19,21
15:44628748 - 44628749,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Deletion,frameshift variant,15,44628748 - 44628749,D663fs,Likely pathogenic,N,-,15:44628748 - 44628749,44628748.0,SPG11,15,0.0011787198622255658,0.0012533923319457587,0.0012631374711489984,0.0011946403980763309,0.001098833097378508,0.0010835960125782323,35,49
15:44629276 - 44629279,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Deletion,frameshift variant,15,44629276 - 44629279,F617fs,Pathogenic,N,-,15:44629276 - 44629279,44629276.0,SPG11,15,0.0007865849041037468,0.0007900535783028613,0.0007587193672215413,0.000782867013834846,0.001141930802199054,0.00045935375896043174,23,22
15:44629304,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,single nucleotide variant,nonsense,15,44629304,S607*,Likely pathogenic,C,G,15:44629304,44629304.0,SPG11,15,0.0003566971809277898,0.0005145742715521684,0.00037700219484572997,0.00039661187563181776,0.00023601914645213353,0.00025927841615709933,10,14
rs1226110412,SPG11,Amyotrophic lateral sclerosis type 5,single nucleotide variant,nonsense,15,44651515,Q478*,Pathogenic,C,T,rs1226110412,44651515.0,SPG11,15,0.00011776749266875569,0.00012550700570287252,0.00011748998984813743,0.00010501399910212158,0.00015895811616586182,8.186835252478514e-05,3,6
15:44651672,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Deletion,frameshift variant,15,44651672,I425fs,Likely pathogenic,N,-,15:44651672,44651672.0,SPG11,15,0.0009512284932412165,0.0007224044252979434,0.0010492862253700427,0.0004670432719001477,0.0011909605965012256,0.001326447947136723,28,38
15:44657171,SPG11,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5,Deletion,frameshift variant,15,44657171,S265fs,Likely pathogenic,N,-,15:44657171,44657171.0,SPG11,15,0.0005077222199389975,0.0006125336958686872,0.0004407503206332245,0.00040706766307344955,0.0005609072589296334,0.0005173521611899927,15,22
15:44657213,SPG11,Amyotrophic lateral sclerosis type 5|Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X,single nucleotide variant,nonsense,15,44657213,Q251*,Likely pathogenic,C,T,15:44657213,44657213.0,SPG11,15,0.0004406808611468869,0.0004968221806838209,0.00028520889678383584,0.0003692869986962553,0.0007098398440703192,0.00034224638550020325,13,18
rs2053207945,CHRNA3,Amyotrophic lateral sclerosis,Deletion,frameshift variant|non-coding transcript variant,15,78601917,L242fs,Likely pathogenic,N,-,rs2053207945,78601917.0,CHRNA3,15,0.0007760777136037048,0.0012150207969415063,0.0006777712596103347,0.0008319956648848981,0.0004493411054145099,0.000706259741167275,23,23
rs2053208751,CHRNA3,Amyotrophic lateral sclerosis,Insertion,frameshift variant|non-coding transcript variant,15,78601933 - 78601934,I237fs,Likely pathogenic,-,G,rs2053208751,78601933.0,CHRNA3,15,0.001114892887558495,0.000853647601813788,0.001048812306197024,0.0013389968326073989,0.0009718599524034525,0.001361147744770811,33,36
rs2053501632,CHRNA3,Amyotrophic lateral sclerosis,Insertion,frameshift variant|non-coding transcript variant,15,78618636 - 78618637,T83fs,Likely pathogenic,-,G,rs2053501632,78618636.0,CHRNA3,15,0.0012540531815095181,0.001274108370765673,0.0011764595265299604,0.0008867653140820961,0.0012630070676057628,0.0016699256285640986,37,47
rs2053539304,CHRNA3,Amyotrophic lateral sclerosis,single nucleotide variant,missense variant|initiator_codon_variant|non-coding transcript variant,15,78620794,M1V,Likely pathogenic,A,G,rs2053539304,78620794.0,CHRNA3,15,0.0019029519509070586,0.0023120444348733245,0.0021963972952161836,0.0018394147490941148,0.001476143332458793,0.0016907599428928775,56,47
rs2544251972,FUS,"Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4",single nucleotide variant,nonsense|non-coding transcript variant,16,31183920,"Q84*, Q85*",Pathogenic,C,T,rs2544251972,31183920.0,FUS,16,0.00014760215503814258,0.00019728821722391797,9.950408690618508e-05,0.0001397484912600607,0.0001359011152655031,0.0001655688645350461,4,4
rs2144138894,FUS,"Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4",Duplication,frameshift variant|non-coding transcript variant,16,31190839 - 31190840,"G464fs, G461fs, G465fs",Pathogenic,N,NN,rs2144138894,31190839.0,FUS,16,0.00018509165668760715,0.0001764723298792711,0.00018511261266512818,0.00023923858381598055,0.00015663833648021038,0.00016799642059744547,5,8
rs2079347087,FUS,Amyotrophic lateral sclerosis type 6,single nucleotide variant,splice acceptor variant,16,31190962,,Pathogenic,G,T,rs2079347087,31190962.0,FUS,16,0.0008548469420095996,0.0009736806053758254,0.000683788264230272,0.0007530571353104589,0.0009790352429911464,0.000884673462140295,25,35
rs2544279075,FUS,"Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4",Deletion,frameshift variant|non-coding transcript variant,16,31191016 - 31191055,"Y480fs, Y483fs, Y484fs",Pathogenic,N,-,rs2544279075,31191016.0,FUS,16,0.0005004811217935001,0.00059180809070075,0.0005681935315601797,0.00034220417250271874,0.000496901106777474,0.0005032987074263775,15,11
16:31191061 - 31191062,FUS,Amyotrophic lateral sclerosis type 6,Duplication,frameshift variant|non-coding transcript variant,16,31191061 - 31191062,"G496fs, G500fs, G499fs",Likely pathogenic,N,NN,16:31191061 - 31191062,31191061.0,FUS,16,0.0006473696915125263,0.0007401511980251225,0.0006017720570864616,0.00056853790670203,0.0005803036109030479,0.00074608368484597,19,11
16:31191062,FUS,"Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4",Deletion,frameshift variant|non-coding transcript variant,16,31191062,"G495fs, G498fs, G499fs",Pathogenic,N,-,16:31191062,31191062.0,FUS,16,0.00011577654439667403,0.0001511212081890687,0.00011929805242403973,5.84763972157987e-05,0.00013833630603096015,0.00011165075812350297,3,6
rs2144140268,FUS,"Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4",Duplication,frameshift variant|non-coding transcript variant,16,31191068 - 31191069,"G500fs, G501fs, G497fs",Pathogenic,N,NN,rs2144140268,31191068.0,FUS,16,0.0008759834663987116,0.00104851530395706,0.0010065276947844241,0.00045645929791650417,0.0009035193390431387,0.0009648956962924314,26,30
rs1596912983,FUS,"Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4",Microsatellite,frameshift variant|non-coding transcript variant,16,31191075 - 31191076,"G500fs, G503fs, G504fs",Pathogenic,N,NN,rs1596912983,31191075.0,FUS,16,0.0007724199344275399,0.001062229326236875,0.0009063835501021041,0.0003766090562486066,0.0010357918160496494,0.0004810859235004647,23,26
rs2079350332,FUS,Amyotrophic lateral sclerosis type 6,Duplication,frameshift variant|non-coding transcript variant,16,31191077 - 31191078,"G503fs, G504fs, G500fs",Pathogenic,N,NN,rs2079350332,31191077.0,FUS,16,0.00012575929601904717,0.00010558960104460524,0.00015591296495042641,0.00016163836906986327,9.139985848975488e-05,0.00011425568654058608,3,1
rs2544279594,FUS,"Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4",Duplication,frameshift variant|non-coding transcript variant,16,31191099 - 31191100,"M507fs, M510fs, M511fs",Pathogenic,N,NN,rs2544279594,31191099.0,FUS,16,0.00010835508799726101,0.00012137703865410539,0.0001371737081888588,0.00010345149899146614,0.00011163476517797672,6.813842897389799e-05,3,5
rs1555509609,FUS,Amyotrophic lateral sclerosis type 6,single nucleotide variant,missense variant|non-coding transcript variant,16,31191109,"R514W, R510W, R513W",Likely pathogenic,A,T,rs1555509609,31191109.0,FUS,16,0.002940987967521494,0.004119489957595357,0.002937711255496696,0.0025020031320553715,0.002985017654169022,0.0021607178382910238,87,77
rs2079351113,FUS,"Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4",single nucleotide variant,splice donor variant,16,31191111,,Pathogenic,G,A,rs2079351113,31191111.0,FUS,16,0.0004423037803173824,0.0005717100231747663,0.00029083395142174954,0.00036951858667196095,0.0005261506100533235,0.00045330573026511166,13,15
rs1596914113,FUS,Amyotrophic lateral sclerosis type 6,single nucleotide variant,splice acceptor variant,16,31191398,,Likely pathogenic,G,C,rs1596914113,31191398.0,FUS,16,0.000631762290758287,0.0008547584552461954,0.0007273304231283827,0.00045655165372064264,0.0004887663841435042,0.0006314045375527099,18,16
16:31191399,FUS,"Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4",single nucleotide variant,missense variant|non-coding transcript variant,16,31191399,"R510S, R513S, R514S",Pathogenic,G,T,16:31191399,31191399.0,FUS,16,0.0027707644327800442,0.0031624892662184016,0.002885722560422856,0.002380541568064127,0.003020731021852967,0.0024043377473418714,82,87
rs121909669,FUS,"Tremor, hereditary essential, 4|Amyotrophic lateral sclerosis type 6",single nucleotide variant,missense variant|non-coding transcript variant,16,31191410,"R518K, R514K, R517K",Pathogenic,G,A,rs121909669,31191410.0,FUS,16,0.0008853155415846425,0.0012390218393843698,0.0006958499574639254,0.0008133199158539972,0.0007730773248344498,0.0009053086703864699,26,32
rs1567479067,FUS,Amyotrophic lateral sclerosis type 6,single nucleotide variant,nonsense|non-coding transcript variant,16,31191412,"Q515*, Q518*, Q519*",Pathogenic,C,T,rs1567479067,31191412.0,FUS,16,0.00038493942081323663,0.00034744238005744385,0.0004986478192950459,0.0003595237247116582,0.00031627261577364847,0.00040281056422838653,11,10
rs544088874,FUS,Amyotrophic lateral sclerosis type 6,single nucleotide variant,missense variant|non-coding transcript variant,16,31191428,"R523M, R520M, R524M",Likely pathogenic,G,T,rs544088874,31191428.0,FUS,16,0.0017982087185362317,0.0027987237344456357,0.0013884641980786874,0.0016996177682003886,0.0017459403423129582,0.0013582975496434877,53,57
rs1555509699,FUS,Amyotrophic lateral sclerosis type 6,single nucleotide variant,missense variant|non-coding transcript variant,16,31191430,"P521S, P524S, P525S",Likely pathogenic,C,T,rs1555509699,31191430.0,FUS,16,0.004010402953641476,0.0029808193789510416,0.0036455046996516534,0.0019670873298766886,0.006315881397508518,0.00514272196221948,119,126
rs1555509699,FUS,"Tremor, hereditary essential, 4|Amyotrophic lateral sclerosis type 6",single nucleotide variant,missense variant|non-coding transcript variant,16,31191430,"P521T, P525T, P524T",Pathogenic,C,A,rs1555509699,31191430.0,FUS,16,0.0006171343955714212,0.0005249886324667968,0.0008394774689403049,0.0007245677017243051,0.0005652582199357709,0.00043137995478992824,18,21
rs1228194239,FUS,Juvenile amyotrophic lateral sclerosis,single nucleotide variant,missense variant|non-coding transcript variant,16,31191434,"Y525C, Y522C, Y526C",Pathogenic,A,G,rs1228194239,31191434.0,FUS,16,0.0029285448364951326,0.003398389426609895,0.0023239309362380546,0.002109844019278809,0.003553221151948627,0.0032573386484002756,87,98
rs2513075471,UNC13A,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,19,17648579,"F554L, F556L",Likely pathogenic,C,A,rs2513075471,17648579.0,UNC13A,19,0.004456184220414337,0.005164043276177884,0.004098269036215332,0.004573096388951099,0.004892563754210495,0.0035529486465168767,133,134
20:761006 - 765794,SLC52A3,Brown-Vialetto-van Laere syndrome 1,Deletion,,20,761006 - 765794,,Pathogenic,N,-,20:761006 - 765794,761006.0,SLC52A3,20,0.0025400910599788413,0.0032605709893569587,0.0021019385547290594,0.0022697234743395975,0.0028591435377417034,0.002209078743726887,76,69
rs1555783467,SLC52A3,Brown-Vialetto-van Laere syndrome 1,single nucleotide variant,missense variant,20,761120,G439D,Likely pathogenic,G,A,rs1555783467,761120.0,SLC52A3,20,0.0036556324157456304,0.003365948021376413,0.004297721833422753,0.002661278241541449,0.0049946651238718075,0.0029585488585157304,109,104
rs767916187,SLC52A3,Brown-Vialetto-van Laere syndrome 1,single nucleotide variant,nonsense,20,763718,Q285*,Pathogenic,C,T,rs767916187,763718.0,SLC52A3,20,0.0002885486362611851,0.0002963746406818328,0.0002943630994538073,0.00027935533686263226,0.00029261682621705006,0.0002800332780906028,8,9
rs2514848897,SLC52A3,Brown-Vialetto-van Laere syndrome 1,Deletion,frameshift variant,20,763780 - 763781,S264fs,Pathogenic,N,-,rs2514848897,763780.0,SLC52A3,20,0.0003581985103006604,0.00045447269437407856,0.0002830517626220415,0.00043291525298256564,0.0003281265314196013,0.00029242631010501494,10,16
rs2514849071,SLC52A3,Brown-Vialetto-van Laere syndrome 1,Deletion,frameshift variant,20,763829,W248fs,Likely pathogenic,N,-,rs2514849071,763829.0,SLC52A3,20,0.0007526916101527698,0.0007546311650101963,0.0008447193709198678,0.0006796670143202836,0.0008728604834156018,0.0006115800170978994,22,22
20:763909,SLC52A3,Brown-Vialetto-van Laere syndrome 1,Deletion,frameshift variant,20,763909,L221fs,Likely pathogenic,N,-,20:763909,763909.0,SLC52A3,20,0.0014168326673153389,0.0019044470609180417,0.0015431590950137114,0.001320161591314294,0.001132103572588742,0.0011842920167419054,42,34
rs1383679424,SLC52A3,Brown-Vialetto-van Laere syndrome 1,Duplication,frameshift variant,20,765290 - 765291,G162fs,Pathogenic,N,NN,rs1383679424,765290.0,SLC52A3,20,0.0007199648056875761,0.0009232212849208022,0.0007034383724454495,0.0005306571085144865,0.0009941843402669194,0.0004483229222902231,21,27
rs769740240,SLC52A3,Brown-Vialetto-van Laere syndrome 1,single nucleotide variant,nonsense,20,765367,Y136*,Pathogenic,C,G,rs769740240,765367.0,SLC52A3,20,0.0006509875058791235,0.0006222652655434418,0.0007448552437859349,0.000706191367994562,0.0007303478248613286,0.00045127782721035,19,22
rs767263985,SLC52A3,Brown-Vialetto-van Laere syndrome 1,single nucleotide variant,missense variant,20,765401,T125I,Likely pathogenic,C,T,rs767263985,765401.0,SLC52A3,20,0.002372464422653765,0.001822289339858408,0.0027568062156407562,0.0013338903949871108,0.0028783968776270696,0.0030709392851554834,71,70
rs1486271481,SLC52A3,Brown-Vialetto-van Laere syndrome 1,single nucleotide variant,nonsense,20,765482,W98*,Pathogenic,G,A,rs1486271481,765482.0,SLC52A3,20,0.0006948734313575383,0.0009436021013197908,0.0007699779463811175,0.0005607163406272065,0.0008354984077775226,0.00036457236068205374,20,15
rs1986662202,SLC52A3,Brown-Vialetto-van Laere syndrome 1,Deletion,frameshift variant,20,765690,L29fs,Pathogenic,N,-,rs1986662202,765690.0,SLC52A3,20,0.00015398506631545902,0.0001690761040009116,0.0001824264490978893,0.00011602109447915915,0.00013260383270824631,0.0001697978512910888,4,5
rs2514853352,SLC52A3,Brown-Vialetto-van Laere syndrome 1,single nucleotide variant,nonsense,20,765724,W17*,Pathogenic,G,A,rs2514853352,765724.0,SLC52A3,20,0.00021953305238752737,0.00032051648677869945,0.00023052904289564278,0.0002335909894030008,0.00016367562746149886,0.0001493531153987949,6,5
rs1568807314,SOD1|SOD1-DT,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31659785,V6M,Likely pathogenic,G,A,rs1568807314,31659785.0,SOD1,21,0.0028594390973410164,0.0034336172749148035,0.002513673787657052,0.0016096020719279843,0.0042898853036103385,0.0024504170485949027,85,76
rs1312702973,SOD1|SOD1-DT,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31659788,C7G,Likely pathogenic,T,G,rs1312702973,31659788.0,SOD1,21,0.0009049331430093748,0.0009623470183212384,0.0008484491251376727,0.001027891808975384,0.0008238026571157503,0.0008621751054968287,27,15
rs1312702973,SOD1|SOD1-DT,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31659788,C7S,Pathogenic,T,A,rs1312702973,31659788.0,SOD1,21,0.0010739173918449035,0.0012380772779919255,0.0009423795746011087,0.0012682876672277348,0.0011495065964697978,0.000771335842933951,32,34
rs762628133,SOD1|SOD1-DT,Amyotrophic lateral sclerosis type 1,single nucleotide variant,non-coding transcript variant|missense variant,21,31659803,D12Y,Likely pathogenic,G,T,rs762628133,31659803.0,SOD1,21,0.002378083676044883,0.0018276519237724396,0.0023034169790064818,0.002524488569657514,0.0032427699841538495,0.0019920909236341294,71,64
rs1202989817,SOD1-DT|SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31659813,V15G,Likely pathogenic,T,G,rs1202989817,31659813.0,SOD1-DT,21,0.0006526745727533271,0.0007411556885712688,0.0006722566355621359,0.0005099921087225391,0.0006645486723472416,0.00067541975856345,19,17
rs121912453,SOD1|SOD1-DT,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31659818,G17C,Likely pathogenic,G,T,rs121912453,31659818.0,SOD1,21,0.003103406621036912,0.002556877952048101,0.004020421681584294,0.0021956541280094967,0.0031811789380084225,0.0035629004055342454,92,97
rs1555836169,SOD1|SOD1-DT,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31659831,F21C,Pathogenic,T,G,rs1555836169,31659831.0,SOD1,21,0.0017360114927089262,0.002613892392884942,0.0015734288247117392,0.001380863892186775,0.0010263366018011713,0.0020855357519600037,51,62
21:31659837,SOD1|SOD1-DT,Amyotrophic lateral sclerosis type 1,single nucleotide variant,non-coding transcript variant|missense variant,21,31659837,Q23R,Likely pathogenic,A,G,21:31659837,31659837.0,SOD1,21,0.0003186399917127729,0.00039490846379553,0.0001764691303056742,0.0003404314676044609,0.000363369590197108,0.0003180213066610915,9,10
rs1169198442,SOD1|SOD1-DT,Amyotrophic lateral sclerosis type 1,single nucleotide variant,non-coding transcript variant|missense variant,21,31659837,Q23P,Likely pathogenic,A,C,rs1169198442,31659837.0,SOD1,21,0.002216646352510637,0.002559221909436831,0.0027997458506282486,0.0013857012795192635,0.0026593393228866993,0.0016792234000821452,66,66
21:31663789,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,splice acceptor variant,21,31663789,,Likely pathogenic,G,A,21:31663789,31663789.0,SOD1,21,0.0010382193042993311,0.0011530745306536094,0.0007482502698929372,0.0007333642094274043,0.001357174925257027,0.0011992325862656777,31,28
rs1555836520,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31663833,L39Q,Likely pathogenic,T,A,rs1555836520,31663833.0,SOD1,21,0.000797505794219434,0.0007780988848498507,0.0009168208992709611,0.0006694615342548011,0.0009197604900102171,0.0007033871627113407,23,20
21:31666473,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31666473,,Likely pathogenic,T,G,21:31666473,31666473.0,SOD1,21,0.0029793718768013427,0.00326227809848243,0.0023572978484332173,0.0021117542287737226,0.003710642607622871,0.0034548866006944732,89,105
21:31666479,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31666479,P67R,Likely pathogenic,C,G,21:31666479,31666479.0,SOD1,21,0.002906983077181848,0.002613787452865505,0.002732717905002281,0.002386826354414702,0.0029915771815132164,0.0038100064921135347,86,100
21:31666482,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31666482,L68P,Likely pathogenic,T,C,21:31666482,31666482.0,SOD1,21,0.001476496113950195,0.0015937113533786471,0.0013358157763352062,0.0007664349361730843,0.0019198610991999479,0.0017666574046640894,44,49
rs2049594204,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31666484,S69P,Likely pathogenic,T,C,rs2049594204,31666484.0,SOD1,21,0.000521848876803705,0.0006744176739555891,0.00032708232145961004,0.000420251416871204,0.0006733821609535601,0.0005141108107785618,15,14
rs2049594311,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31666493,H72Y,Likely pathogenic,C,T,rs2049594311,31666493.0,SOD1,21,0.0005413981977705398,0.0008417818573619527,0.000382399614972552,0.0004586931108042104,0.0004449540945385738,0.0005791623111754095,16,12
rs2516660280,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31667259,H81Y,Likely pathogenic,C,T,rs2516660280,31667259.0,SOD1,21,0.001008481172630965,0.0012263573139011485,0.0010172626938262871,0.0008120227142064347,0.0012013748503276738,0.0007853882908932793,30,33
rs121912458,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31667260,H81R,Pathogenic,A,G,rs121912458,31667260.0,SOD1,21,0.0008634668575410953,0.0010266024505883012,0.0010124532406790125,0.0005773929114617402,0.0006452769274568688,0.0010556087575195534,25,23
rs80265967,SCAF4|SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31667290,D91V,Pathogenic,A,T,rs80265967,31667290.0,SCAF4,21,0.0012207471778296615,0.0017418258369247244,0.0012528843075639983,0.001271988833288655,0.0008432687232622245,0.0009937681881087047,36,44
21:31667296 - 31667297,SOD1,Amyotrophic lateral sclerosis type 1,Duplication,,21,31667296 - 31667297,,Likely pathogenic,N,NN,21:31667296 - 31667297,31667296.0,SOD1,21,0.0010100004771999157,0.0011300390164716628,0.0011978129816285208,0.001182704968795655,0.0008290538574180278,0.0007103915616857125,30,35
rs121912437,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31667298,G94S,Pathogenic,G,A,rs121912437,31667298.0,SOD1,21,0.0024078097862657967,0.0025238146295323213,0.0024676046409817494,0.0019993132820916954,0.0017578281753110046,0.003290488203412213,72,74
rs121912437,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31667298,G94C,Pathogenic,G,T,rs121912437,31667298.0,SOD1,21,0.0028576475637673753,0.0031847717313478676,0.0033778830393754546,0.0017526375217023643,0.0025757426151581672,0.003397202911253024,85,81
rs121912438,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31667299,G94A,Pathogenic,G,C,rs121912438,31667299.0,SOD1,21,0.002541991560601663,0.003351333580846637,0.0021890622335267113,0.0026849552591413695,0.002107959488356075,0.0023766472411375227,76,60
rs1555836803,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31667308,D97V,Likely pathogenic,A,T,rs1555836803,31667308.0,SOD1,21,0.0015400988783231052,0.001840544898134768,0.0012123441854677282,0.0014946202231454636,0.0012564361806447519,0.0018965489042228152,46,45
rs1568810715,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31667322,D102N,Pathogenic,G,A,rs1568810715,31667322.0,SOD1,21,0.0016305260664614227,0.001704925101225078,0.0015450313515949898,0.002074921491657295,0.0010136727554369042,0.0018140796323928455,48,42
rs1568810715,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31667322,D102H,Pathogenic,G,C,rs1568810715,31667322.0,SOD1,21,0.002640762483859295,0.0035123711909798463,0.002099561950302768,0.0020352592331821166,0.002280471716459529,0.0032761483283722153,79,73
rs121912445,SOD1,Abnormal central motor function,single nucleotide variant,missense variant,21,31667331,I105F,Likely pathogenic,A,T,rs121912445,31667331.0,SOD1,21,0.003523074691686283,0.003582024965618769,0.0034191014125767604,0.002785536624727396,0.0036636512619189756,0.004165059193589514,105,115
rs121912440,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31667337,L107F,Pathogenic,C,T,rs121912440,31667337.0,SOD1,21,0.0012824283643031857,0.001595073801258039,0.00099712796890649,0.0010205800654172778,0.001542404195882365,0.001256955790051757,38,39
rs1601158483,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31667353,C112Y,Pathogenic,G,A,rs1601158483,31667353.0,SOD1,21,0.002487643823378363,0.003649674920003775,0.0023871029784010987,0.0016437831992854386,0.002029780018562733,0.0027278780006387724,74,63
rs74315452,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31667356,I113T,Pathogenic,T,C,rs74315452,31667356.0,SOD1,21,0.00036997614283564657,0.0005337534165795388,0.000316452680034587,0.00023715157304558088,0.0005429246673953871,0.0002195983771231392,11,9
21:31667357,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31667357,I113M,Likely pathogenic,C,G,21:31667357,31667357.0,SOD1,21,0.0031164205587059153,0.0037423120137210068,0.0041398529955620446,0.0027370599150519158,0.0022919049089119583,0.0026709729602826496,93,75
rs750335577,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31667360,I114M,Likely pathogenic,T,G,rs750335577,31667360.0,SOD1,21,0.0016403065016681276,0.0017402709239409554,0.001138084573243166,0.000928330165550148,0.002587208492073378,0.0018076383535329922,49,37
rs1568810789,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31667362,G115A,Pathogenic,G,C,rs1568810789,31667362.0,SOD1,21,0.0006947612242194812,0.0006297065426182771,0.0011201880082307748,0.00042152355585087735,0.0008767708126826099,0.0004256172017148666,20,24
21:31667364,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31667364,R116S,Likely pathogenic,C,A,21:31667364,31667364.0,SOD1,21,0.00352602434216584,0.004288414506468446,0.004224290491000104,0.002844075384697934,0.0023922161643988946,0.003881125164263823,105,115
21:31668471,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31668471,V120F,Likely pathogenic,G,T,21:31668471,31668471.0,SOD1,21,0.002777890758564611,0.003766736522861195,0.0019149536533401316,0.0017589879897906768,0.0032394245581684345,0.003209351068662619,83,95
21:31668477,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31668477,E122K,Likely pathogenic,G,A,21:31668477,31668477.0,SOD1,21,0.0029068409078798776,0.003030023355708955,0.0026880507978851395,0.00204325074997538,0.002642837968399641,0.004130041667430273,86,102
rs1568811372,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31668489,D126N,Likely pathogenic,G,A,rs1568811372,31668489.0,SOD1,21,0.001321856920629248,0.0016691207684904849,0.0013675997271459697,0.0011220411707889572,0.0012912358809896063,0.001159287055731222,39,43
21:31668490 - 31668491,SOD1,Amyotrophic lateral sclerosis type 1,Duplication,frameshift variant,21,31668490 - 31668491,K129fs,Pathogenic,N,NN,21:31668490 - 31668491,31668490.0,SOD1,21,7.052020275209958e-05,6.115714707041304e-05,7.87881364805249e-05,8.223910290593026e-05,5.6835272948227165e-05,7.358135435540256e-05,2,1
rs1164911383,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31668490,D126A,Likely pathogenic,A,C,rs1164911383,31668490.0,SOD1,21,0.004701406001964558,0.003233139658935846,0.005884585752357291,0.005339294408473731,0.0049831974268059525,0.0040668127632499705,140,158
rs121912454,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31668493,L127S,Pathogenic,T,C,rs121912454,31668493.0,SOD1,21,0.0016607111047764259,0.002453496934599088,0.0015403152313400149,0.0008942723031874976,0.0019135883756577947,0.0015018826790977344,49,42
rs1027128618,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31668509,N132K,Likely pathogenic,T,G,rs1027128618,31668509.0,SOD1,21,0.002919612676003799,0.004276253496625477,0.0032155674652921394,0.0024218238306903802,0.0025279266293883125,0.0021564919580226894,87,83
rs2049618449,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31668513,E134K,Likely pathogenic,G,A,rs2049618449,31668513.0,SOD1,21,0.0025144442699090333,0.0031026537135378065,0.0021803518746878405,0.0019418708748285454,0.0025822254572133037,0.002765119429277671,75,73
rs1568811426,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31668514,E134G,Pathogenic,A,G,rs1568811426,31668514.0,SOD1,21,0.00016612376415148483,0.00024652692074972885,0.00018496395691223918,0.0001422195569924207,0.00010931788725750024,0.00014759049884553518,4,8
rs1568811489,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31668538,G142V,Likely pathogenic,G,T,rs1568811489,31668538.0,SOD1,21,0.0003422543607103596,0.0005007297488702009,0.00033362785043964657,0.000184451861274801,0.00042246098883287896,0.0002700013541342704,10,11
rs1482760341,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31668548,L145F,Pathogenic,G,T,rs1482760341,31668548.0,SOD1,21,0.0009921057559083078,0.0009699197628480908,0.0009397638494467206,0.0010511501759516715,0.0006169609768319975,0.0013827340144630582,29,33
rs121912447,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31668549,A146T,Likely pathogenic,G,A,rs121912447,31668549.0,SOD1,21,0.0034671597809130873,0.003848502102069457,0.0032174698268686622,0.0020319906572013055,0.004717643247880168,0.0035201930705458413,103,105
rs1131690781,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31668550,A146V,Likely pathogenic,C,T,rs1131690781,31668550.0,SOD1,21,0.000790114838212945,0.0010839097495892733,0.0007206014543843358,0.0008229262218888873,0.0008503656675056406,0.00047277109769658767,23,28
21:31668551,SOD1,Amyotrophic lateral sclerosis type 1,Deletion,frameshift variant,21,31668551,C147fs,Likely pathogenic,N,-,21:31668551,31668551.0,SOD1,21,0.0012601141477346226,0.0022994064331634976,0.000969342983144855,0.0008876108811766955,0.0010148436118160916,0.0011293668293719734,37,35
rs1568811515,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31668552,C147R,Likely pathogenic,T,C,rs1568811515,31668552.0,SOD1,21,0.0038872202756215384,0.005047402000574346,0.0025237911678189767,0.0023142377425740697,0.005415657700719303,0.0041350127664209965,116,123
rs1424014997,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31668562,I150S,Likely pathogenic,T,G,rs1424014997,31668562.0,SOD1,21,0.0022706747269082843,0.003666900734069041,0.0017169708278960076,0.0016488823334048978,0.0024724684962221617,0.0018481512429493149,67,67
rs1424014997,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31668562,I150N,Likely pathogenic,T,A,rs1424014997,31668562.0,SOD1,21,0.004276332136998312,0.006696640884183977,0.004606899777964582,0.0032043225221180206,0.004138297212976423,0.002735500287748557,127,116
rs2123437030,SOD1,Amyotrophic lateral sclerosis,single nucleotide variant,missense variant,21,31668563,I150M,Likely pathogenic,T,G,rs2123437030,31668563.0,SOD1,21,0.00109795248239792,0.0013014689519390936,0.0013183497359505502,0.0006613205870597032,0.0011923394220301653,0.0010162837150100863,32,27
21:31668568,SOD1,Amyotrophic lateral sclerosis type 1,single nucleotide variant,missense variant,21,31668568,I152N,Likely pathogenic,T,A,21:31668568,31668568.0,SOD1,21,0.0018829987377899336,0.0018573151921990856,0.0012741936143839856,0.001662353259289728,0.0021513293234504817,0.0024698022996263885,56,67
rs2145927350,CHCHD10,Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Autosomal dominant mitochondrial myopathy with exercise intolerance|Lower motor neuron syndrome with late-adult onset,Indel,missense variant,22,23767590 - 23767591,R15L,Pathogenic,N,-,rs2145927350,23767590.0,CHCHD10,22,0.0009409122469474356,0.0009220619978007889,0.0009516385425287972,0.0005620199255334519,0.0011410053963860725,0.0011278353724880673,28,23
rs387906710,UBQLN2,Amyotrophic lateral sclerosis type 15,single nucleotide variant,missense variant,X,56565362,P497S,Pathogenic,C,T,rs387906710,56565362.0,UBQLN2,X,0.002194566113764852,0.0018794260254873668,0.0026955768179564156,0.0018102865832404997,0.001751051545049071,0.002836489597090907,65,77
rs387906709,UBQLN2,Amyotrophic lateral sclerosis type 15,single nucleotide variant,missense variant,X,56565363,P497H,Pathogenic,C,A,rs387906709,56565363.0,UBQLN2,X,0.00031045779437685454,0.00028897499663183197,0.0003423547244437843,0.00014963111601458192,0.00034810601015985786,0.0004232221246342166,9,6
rs387906711,UBQLN2,Amyotrophic lateral sclerosis type 15,single nucleotide variant,missense variant,X,56565389,P506T,Pathogenic,C,A,rs387906711,56565389.0,UBQLN2,X,0.002014254171042064,0.0028795999616996223,0.0016076852123027739,0.0014126677692205172,0.0018860526159412566,0.0022852652960461484,60,55
rs2519963370,UBQLN2,UBQLN2-related disorder,single nucleotide variant,missense variant,X,56565390,P506L,Likely pathogenic,C,T,rs2519963370,56565390.0,UBQLN2,X,0.00399114280982837,0.004539672411781457,0.003893988855186334,0.001685763540505096,0.005043028423681581,0.004793260817987383,119,126
X:56565536,UBQLN2,Amyotrophic lateral sclerosis type 15,single nucleotide variant,missense variant,X,56565536,P555S,Likely pathogenic,C,T,X:56565536,56565536.0,UBQLN2,X,0.000996055804875309,0.001068246263297179,0.0013086575998297616,0.0005259106197613144,0.0008449946383712894,0.001232469903117,29,25
